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Abstract 
Scaffolds suitable for trabecular bone regeneration were produced via the gel-cast foaming 
process using the melt-derived glass composition SBP-3. A problem common to most 
bioactive glass compositions that undergo sintering in order to achieve scaffold form is that 
they crystallise, lowering bioactivity as well as incurring mechanical instability of the 
structure via unpredictable local degradation. The scaffolds did not exhibit significant bulk 
crystallisation upon sintering and the presence of potassium sodium sulphate crystals were 
not detected on the surface, which were formed with a previously studied composition 
ICIE16.  
The process was then optimised further and up-scaled to produce scaffolds in sufficient 
quantities for an in vivo ovine condyle defect study (undertaken at University College 
London by Prof. Allen Goodship and Prof. Gordon Blunn). Despite possessing a relatively 
high network connectivity - 2.31 - and low bioactivity from SBF studies, results from the in-
vivo study concluded that the SBP-3 scaffolds performed better than the original 45S5 
Bioglass granules, displaying 99 % bone aposition over a period of 91 days, in addition to the 
new bone more closely resembling the trabecular bone structure. 
Work was then carried out to simplify the process, switching from a chemical polymerisation 
process to a thermal gelation process, thus allowing for greater optimisation of the process. 
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1 Introduction 
As the world’s population and average life expectancy increases, the number of patients 
requiring bone grafts each year has increased also. Bone grafts are needed as a result of 
pathological causes or physical injuries, and in the United States alone over 1.5 million of 
such procedures were performed in 20051.  Two forms of natural bone grafts are available - 
autografts and allografts. An autograft procedure involves a prerequisite operation to take a 
section of bone from the patient and using that to replace the defect. The problem with this 
however is that the patient will still have to contend with the same net loss of bone, with 
the probability that pain and discomfort will be experienced even after decades. The other 
option is allograft, where the bone is taken from a donor which in most cases originates 
from the femoral head in hip replacement operations. While lowering costs and operation 
time, this procedure carries the risk of disease transmission as well as the possibility of 
rejection by the host body2, not to mention the limited stock available in bone banks. 
Another issue with allografts is that the technique used for sterilisation weakens the bone 
structure of the graft. 
 
Synthetic bone grafts can be made from a wide variety of materials, including ceramics, 
metals and polymers. Alloys such as Ti-6Al-4V are designed to remain in the body and have 
drawbacks and since their stiffness is much greater than the surrounding bone, stress 
shielding will occur, causing loss in bone density. Another problem associated with implants 
is the generation of wear particles that can cause inflammation to the surrounding tissue, 
leading to aseptic loosening3. Certain bioceramics are resorbable and bioactive. The first 
bioactive material was the glass composition 45S5 discovered by Hench in 1969, which was 
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shown to elicit a specific biological response after implantation. It was found to form a 
strong interface to bone without the formation of a fibrous encapsulation4 and as a result 
has been commercialised as Bioglass® in a wide variety of products, ranging from 
Novabone®, which is used as a bone graft substitute, to Perioglass®, used to treat 
periodontal defects.    
 
Another strategy for bone repair is hard tissue engineering, where the goal is focused on the 
synthesis of artificial scaffolds that mimic the structure of trabecular bone, acting as a 
temporary support for the bone defect while encouraging new bone to grow in from the 
surrounding tissue before dissolving away. Osteogenic cells can even be seeded onto the 
scaffolds prior to implantation to aid in vitro growth. With this approach the complications 
from the aforementioned procedures can be eliminated. Ideal bone grafts and scaffolds for 
bone tissue engineering must have an interconnected pore structure so that they can act as 
temporary templates for bone growth in three dimensions. 
 
The major problem associated with 45S5 is its tendency to crystallise during the sintering 
process due to its small processing window, which is unfavourable in scaffold synthesis since 
crystalline regions will require a longer period dissolution to initiate and hence form an 
interface with bone5. Moreover, not all parts of the scaffold will crystallise and so the 
problem of differential dissolution occurs within the one sample. As a result, the mechanical 
stability of the scaffold over time cannot be predicted.  
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Porous scaffolds from melt derived bioactive glasses that do not crystallise have been made 
by Wu et al. using the compositions ICIE16 and ICIE16M through the gel casting method6. 
However, they found that small surface crystals of sodium potassium sulphate formed from 
the reaction between the glass and the ammonium sulphate initiator. It is not clear how 
these crystals affect cell response, mechanical properties and bioactivity of the composition. 
 
This study aims to further the work of Wu et al. by expanding on the number of 
compositions investigated and to try and limit the formation of surface sodium potassium 
crystals. In order to maintain the sintering properties of the ICIE series without 
crystallisation these compositions would have to incorporate a number of components in 
order to increase the sintering window, defined as the range between the glass transition 
temperature and the crystallisation temperature of the glass.  
 
An alternative method was also devised to simplify the original gel-casting process by 
changing the gelling agent used. Lowering the amount of variables in a system will greatly 
aid in optimising processing parameters for a scaffold suitable for bone regeneration.  
 
        17 
2 Literature Review  
Due to the deficiencies of autograft procedures (Chapter 1), synthetic bone grafts are 
needed. A strategy has been to try to mimic trabecular bone as much as possible.  
 
2.1 Design criteria for artificial bone grafts 
A number of criteria has to be met for an ideal artificial bone scaffold to be successful7,8,9, 
which include: 
 The scaffold material has to be bioactive, that is, to be able to bond to existing bone 
surrounding the implantation site through an in vivo surface reaction 
 The material has to be biocompatible such that it will not illicit any adverse immune 
response such as fibrous encapsulation 
 Osteogenic cells should be able to grow both on the scaffold's surface and its interior 
structure. This means that it must exhibit an interconnected porous structure to act 
as a template for 3D growth. An interconnected pore network is desired since there 
is a limitation on diffusion of nutrients to cells past a depth of 200 µm10   
 The interconnect size between pores should be larger than 100 µm to allow for 
vascularisation of the scaffold, ensuring nutrients can reach the inside cells and 
waste products can be taken away 
 The mechanical properties of the scaffold should be such that the scaffold can share 
load with the host bone and be able to withstand handling conditions in addition to 
normal operating procedures for the implant site 
        18 
 Cells that attach to the scaffold must be induced into becoming bone cells. This is 
achieved by the material's dissolution products that signals for such a differentiation 
 The scaffold must degrade at the same rate as the bone is repaired - too fast a 
dissolution will lead to the mechanical compromise of the graft 
 
There is some disagreement in the literature as to some of these criteria and which 
are absolutely necessary. The most contentious are pore network specifications and 
mechanical property requirements. In the early years of scaffold research it was 
theorised that the minimum pore size should be 100 µm to give enough space for 
blood and cells to flow into the scaffold. Karageorgiou et al. however recommended 
a minimum pore size of 300 µm to enhance the vascularisation of the scaffold 
interior, leading to direct osteogenesis without prior osteochondral formation11. An 
important aspect that is often overlooked is that the rate of remodelling of the 
defect and scaffold are important. Scaffolds can degrade through solution mediated 
dissolution or by cellular action (e.g. macrophage or osteoclast attack). An ideal 
scaffold should remodel as the new bone is remodelled, without losing its 
mechanical properties too rapidly. A scaffold that remains in place too long may 
cause a prolonged immune response and fibrous tissue ingrowth12. In this work, the 
aim is to produce scaffolds with a minimum interconnect size of 100 µm between 
pores of at least 300 µm from a biodegradable glass. 
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2.2 Common materials used in bone grafts 
There are a variety of materials available as bone graft substitutes. The most common 
synthetic bone grafts are bioactive ceramics such as calcium phosphates and bioactive 
glasses. Both of these form a bond with bone through formation of a surface active hydroxyl 
carbonate apatite (HCA) layer that is similar to bone mineral. Calcium phosphate ceramics 
are used for their similarity to the mineral phase of bone, examples of which include 
tricalcium phosphates and artificial hydroxyapatite13 [(Ca10(PO4)6(OH)2]. The problem with 
tricalcium phosphates however is that they tend to degrade too quickly for adequate bone 
formation to occur14, while conversely artificial hydroxyapatite degrades too slowly15. In 
degrading slowly, synthetic hydroxyapatite's ability to remodel is reduced12.  
 
It has been found that by substituting silicon into synthetic HA, its degradation rate and 
bioactivity can be increased, with the optimal amount of substitution to be 0.8 wt% Si16. The 
main factor for the faster degradation has been attributed to the system being more 
disordered as a result of the silicon substitution, introducing defects that increase the 
process of ion exchange17. Si-HA has been commercialised in the form of Actifuse® (Apatech, 
Elstree, UK), a porous form of silicon substituted hydroxyapatite.  
 
Bioactive glasses were the first bioactive material to be used in bone grafts, the original 
composition was called Bioglass and was invented by Hench in 197118. Since glass is 
amorphous, it allows for rapid dissolution compared to a crystalline ceramic, and so HCA 
forms quicker19. At the same time, they also release osteogenic ions to that are found to 
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upregulate genes related to oesteoblasts, and so the material is osteoinductive in that it 
stimulates bone growth away from its local site. It was found that the soluble silicon and 
calcium ions in the glass were responsible for the gene stimulation20. Currently there are a 
number of bioactive glass products available commercially, such as Perioglass®, Novabone®, 
BonAlive® and Stronbone®, all packaged as glass granules. These granules would typically be 
mixed with the patient's blood before being packed into the defect site.  The reason that 
there are currently no commercialised bioactive glass scaffolds is that these compositions 
undergo crystallisation during the crucial sintering step needed to retain the scaffold 
structure73, and as a result not only would the bioactivity of the scaffold drop, the 
mechanical properties will become unpredictable also as the crystalline areas are more 
resistant to degradation.  
 
2.3  Bioactive glass composition and structure 
It is important to gain an understanding of the structure of glass since it affects its 
degradation rate and apatite formation, which in turn affects its bioactivity21.  
 
Glass is an amorphous inorganic material that possesses a glass transition temperature (Tg). 
A glass transition temperature can be defined as the temperature above which the bonds in 
the glass possess enough energy to break and reform, allowing for more atomic movement 
in the structure 22 . When cooled from the melt, the volume of a glass decreases 
proportionally to the cooling rate. Once the glass transition temperature is reached 
however the glass structure does not relax at the cooling rate used since the atoms no 
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longer possess the energy to break and reform bonds23. In a given glass composition, the 
glass transition temperature differs according to the cooling rate used, with a higher Tg 
arising from a higher rate of cooling. Standard convention expresses Tg at a rate of 20 
K/minute. When sintering particles of glass together, Tg must be exceeded in order for 
viscous flow of the glass to occur. The heating rate is also important during sintering. A 
slower heating rate should be used during the sintering of glasses in order to lower the Tg 
slightly and further expand the sintering window (Section 2.6).   
 
2.3.1 Network former 
The network former in bioactive glass is silica24. It forms the network which holds the overall 
structure together, since they have multiple bonds that link to an oxygen atom, which in 
turn bonds to other network formers.  This oxygen atom which connects the network 
formers is referred to as a bridging oxygen and is a bond that links the two silicon atoms 
(Figure 2.1).  
 
Figure 2.1: The Si-O-Si network 
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In a silica network, the bridging oxygens form a tetrahedron around each silicon atom and it 
is through the interconnecting corners that the disordered three dimensional structure of 
glass is obtained25,26. Through studies of the bond angles and bond lengths between the 
oxygen and the silicon atoms in the tetrahedra, the bond is most likely to be a mixed bond 
comprising of covalent and ionic elements27.  
 
2.3.2  Network modifiers 
Network modifiers are metallic oxides that alter the chemistry of the bonding in the 
network such that they disrupt the formation of bridging oxygens (Figure 2.2).The bond 
between the modifier ion and the oxygen are ionic in nature. 
 
Figure 2.2: A non-bridging oxygen created by a network modifier 
Typically, network modifiers are employed to lower the melting point of commercial glasses 
and therefore save on costs. This property of the modifiers also hold true for bioactive 
glasses, but in addition other properties that are beneficial to bone regeneration are 
available depending on the specific modifier used. Perhaps the most important aspect is 
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that increasing the network modifiers increases the dissolution rate of glass in body fluid. 
However, release of certain modifiers can also stimulate cells. Examples of modifiers in 
bioactive glasses are oxides of calcium, potassium and strontium, and the additional 
properties that each contributes will be discussed further in section 2.6.  
 
2.3.3  Intermediate oxides 
Intermediate oxides such as zinc oxide and magnesium oxide can take on the role of either a 
network former or a network modifier, depending on the glass composition in question28. 
While they cannot form a glass structure by themselves like network formers, they can 
participate in the network by substituting a network former.  
 
2.3.4  Q structure and Network connectivity 
The Q structure describes the number of bridging oxygens around a network former. A Q 
structure of 2 would mean that two bridging oxygens are surrounding the network former in 
question (Figure 2.3).  
 
Figure 2.3: Diagrams of a silicon atom possessing a) Q
2
 strcuture b) Q
1
 strcuture 
The network connectivity describes the average number of bridging oxygens connected to 
each network former throughout the whole system29. The lower the value is, the more 
disrupted the glass network becomes and so is more susceptible to degradation. Pure silica 
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glass would theoretically have a network connectivity of 4 since it is only composed of 
silicon and oxygen. Bioactive glasses tend to have a low network connectivity around the 
region of 2, since it is ideal for the network to be as disrupted as possible allowing for fast 
dissolution whilst still being able to maintain a stable mechanical structure.  
The network connectivity of a particular glass composition can be obtained using the 
following equation66: 
      
                                        
                  
 
(2.1) 
If a composition is composed of 50 mol% silica and 50 mol% calcium oxide, then its network 
connectivity would be 2, since the equation simplifies to: 
      
        
  
   
(2.2) 
The network former, silica in this instance, can form a maximum of four bridging oxygens, 
one for each bond it can create. The mol% of silica is therefore multiplied by 4 to give the 
number of bridging oxygens it can contribute to the system. Each network modifier in the 
system, regardless of its valency, such as Na+ or Ca2+, will break a single bridging oxygen to 
give two non-bridging oxygens. This is taken into account in the top line of equation 2.1. 
 
A component found in most bioactive glasses is phosphate, due to its ability to help form 
hydroxycarbonate apatite. In depth study into its structure utilising Nuclear Magnetic 
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Resonance (NMR) has found that phosphate actually forms its own phase within the glass as 
orthophosphate30, rather than integrating into the network as previously thought. Several 
research groups now agree that the phosphate in bioactive glasses are present as 
orthophosphate, rather than forming part of the glass network through Si-O-P bonds. 
However the exact role of phosphate in the glass network is still a subject of some 
controversy. Initially, because phosphate is a network former in its own right (e.g. 
phosphate glasses31), it was thought to become part of the silica network. Molecular 
dynamics models supported this theory32. However, O’Donnell found through MAS-NMR 
studies that phosphorus did not form any Si-O-P bonds, postulating that it instead forms 
isolated groups of orthophosphate33. This means that orthophosphate forms its own phase 
within the glass network, hence why two glass transition temperatures can be often seen in 
glasses containing more than 6 mol% phosphate content34, and why phosphate leaches 
from the glass very quickly when immersed in aqueous solutions35. Work by Pedone et al. 
proved this to be the case36. 
 
Figure 2.4 shows a schematic of orthophosphate, which are present as separate structural 
units in bioactive glasses, which do not take part in the silica network (Si-O-P bonds do not 
form). The single bonded oxygen atoms will be charge balanced (ionic bonds) with the 
cations in the glass structure (e.g. Na+ and Ca2+), in effect reducing the number of non-
bridging oxygens available to disrupt the network. Since each cation will cause two non-
bridging oxygens to form, each of the three single bonded oxygens will reduce the number 
of non-bridging oxygens in the network connectivity equation by two, in total giving a 
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reduction of six non-bridging oxygens for each mol% of phosphorus. An example of a glass 
composition involving phosphorus is shown below. 
 
 
Figure 2.4: Structure of orthophosphate 
Taking these arguments into account, adding phosphate to a composition would reduce the 
number of non-bridging Si-O bonds in the glass because the separate orthophosphate units 
must be charge balanced by the cations. Therefore calculation of the network connectivity 
of a composition containing 50 mol% silica, 25 mol% sodium oxide, 20% calcium oxide and 5% 
phosphate requires the NC equation to be modified: 
      
                        
  
 
      
           
  
 
     
    (2.3) 
This means that with this composition, the network connectivity is 2.8, so the majority of 
the Q species within the structure are mainly Q3, followed by Q2. 
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A commonly used composition is 13-93 37,38,39, which contains MgO and K2O. K
+ performs a 
function similar to Na+ in the glass composition, taking the role of a network modifier. Some 
recent bioactive glass compositions also contain ZnO40. MgO and ZnO can behave as 
intermediate oxides. They can act as a network modifier or former in the bioactive glass 
network depending on their coordination number, which may change in accordance with 
their atomic surroundings, and hence these intermediates may behave as a modifier or a 
former in different compositions.  NC refers to their network connectivity values if the 
intermediate oxides are assumed to act as network modifiers, while the NC' values assume 
them to be network formers. In reality Mg is likely to act as a network modifier and a 
proportion of it will act as an intermediate. Watts et al. found that in compositions with a 
range of MgO content typically used in bioactive glasses, around 14 % of the MgO will act as 
a network former41. This means that an idea of the actual network connectivity of a glass 
composition containing intermediate oxides such as MgO can be attained without the use of 
nuclear magnetic resonance (NMR) by adapting the NC formula to treat MgO as a network 
modifier, save for 14 % of the MgO content that is to be treated as a network former. 
 
2.4           Sintering 
Sintering is used to reduce the porosity of a material and to improve its properties such as 
strength, electrical and thermal conductivity. It is driven by the diffusion of atoms from one 
part of the material to another, and by the decrease in surface area and lowering of the 
surface free-energy42. In this study the main factor for sintering is to fuse the green body 
into a solid porous structure such that it can be handled and implanted into the body. There 
are a number of mechanisms that material transfer can take, such as vapour transport, grain 
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boundary diffusion and plastic deformation. Since glasses are amorphous and do not 
possess a long range order or grains, lattice diffusion and grain boundary diffusion cannot 
take place. In silicate glasses, the prevalent mechanisms are viscous flow and surface 
diffusion. Typically during sintering, densification occurs as individual particles normally 
separated by packing porosity begin to flow together as material transfers through diffusion 
from a high concentration to a lower one. This initiates at the junction between two 
adjacent particles to form a neck. Once the neck has formed, it widens as more material 
flows into it through viscous flow and surface diffusion, reducing the porosity of the sample 
and fusing the glass particles.  
 
2.5  Bioactive glass dissolution and apatite formation 
The currently accepted theory for the in-vivo degradation and bonding to bone of bioactive 
glasses was proposed by Hench43 based on his observations on soda-lime-silica systems. 
After implantation, dissolution starts with rapid ion exchange taking place between the 
network modifiers (such as Na+ and Ca2+) and the surrounding ions such as H+ and H3O
+. This 
influx of ions into the surrounding will cause the local pH to rise, and when it reaches the 
region of 9 and above the Si-O-Si bond within the glass will start to break, leading to the 
breakdown of the silica network. Soluble silica in the form of Si(OH)4 will detach from the 
glass bulk, leaving silanol groups (Si-OH) on the surface. In time the silanol groups form an 
alkaline depleted layer of silica. This causes calcium ions (Ca2+) to migrate from the inside of 
the glass through to the outside solution. On route they are met by phosphate groups (PO4
3-) 
as they move through the silica rich layer, which causes the formation of a CaO-P2O5 film 
overlaying the layer. Other ions from the solution such as carbonates and phosphates will 
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now be incorporated into the film and crystallise to form the hydroxycarbonate apatite layer. 
The adsorption and desorption of growth factors on the HCA surface allows for progenitor 
cells to attach onto and differentiate to osteoblasts. Osteoblasts are bone producing cells 
that construct an extracellular matrix around them which later crystallises into the mineral 
phase of bone. Combined with the collagen fibres that intertwine with this inorganic matrix, 
the composite structure of bone is formed.  
 
The current widely accepted in vitro method to test for bioactivity in materials is the 
simulated body fluid method (more details in Section 3.5.7) devised by Kokubo44. SBF 
(simulated body fluid) testing involves immersing the samples in a fluid comparable to that 
of human blood plasma in terms of ion concentration, with the sample amount in the ratio 
of 150 mg to 100 ml of SBF. When bioactive materials are immersed in SBF, their dissolution 
products should leach and HCA should deposit on the surface of the material. This can then 
be detected by x-ray diffraction or infra-red spectroscopy.  
 
Bohner observed that this may not be the best test for bioactivity since SBF is metastable 
towards apatite formation, so in some cases it can just be a matter of time before apatite 
develops even if the material isn’t bioactive45.  Another issue is that serum in vivo is in 
equilibrium at 5% CO2 atmosphere, whereas this is not taken into account in the Kokubo 
method. Apatite may form from heterogeneous nucleation on scratches inside of the 
solution container and so may give rise to false positives. Lastly, there are materials that 
give rise to apatite formation in vitro that do not bond to bone in vivo, such as calcium 
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sulphate hemihydrates46.  Despite these deficiencies, SBF testing can give a general indicator 
of bioactivity in a new material.  
 
2.6 Network Connectivity and bioactivity 
Calculating the network connectivity of a particular glass composition gives a good 
indication of its overall bioactivity21. The greater the network connectivity, the more 
resistant the glass is to degradation and hence the lower its bioactivity since the ability to 
form HCA is impeded (see Section 2.4). Conversely, too low a network connectivity will 
imply that the glass structure does not possess enough bridging oxygens to hold it together, 
and will simply degrade much too quickly, causing an alkali burst effect in vivo. Glasses that 
fall into this category possess a network connectivity of fewer than 266. Typically bioactive 
glasses fall into the range of 2 to 2.5, for example Bioglass has a network connectivity of 
2.11. Table 1 shows the composition and network connectivities of some bioactive glasses. 
BonAlive has an NC of 2.54 due to its higher silica content. The composition 13-93 has a 
rather high network connectivity of 2.59 – 3.01 (depending on the amount of Mg that takes 
a network forming role) which suggests that its bioactivity will be lower compared to the 
other two47. 
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Table 1: Compositions of bioactive glasses and their network connectivity values 
  SiO2 Na2O CaO K2O MgO P2O5 NC NC' 
BonAlive 53.80 22.70 21.80 0.00 0.00 1.70 2.54 2.54 
13-93 54.60 6.00 22.10 7.90 7.70 1.70 2.59 3.01 
Bioglass 46.10 24.40 26.90 0.00 0.00 2.50 2.11 2.10 
 
Studies by Eden et al. found that bioactivity starts dropping at a network connectivity value 
of 2.6; and above 2.7 the composition displayed hardly any bioactivity48. While his glass 
series did not contain any intermediate oxides, this can be used as a rough guide when 
designing new glass compositions. Inclusion of intermediate oxides will increase the 
network connectivity of the glass further (Section 2.3) and so will likely decrease the 
bioactivity of the glass slightly compared to a composition that does not contain 
intermediate oxides. It is of worth to note that the commonly used composition 13-93 
(54.60 mol% SiO2, 6.00 mol% Na2O, 22.10 mol% CaO, 7.90 K2O, 7.70 MgO, 1.70 mol% P2O5) 
still exhibits bioactivity when it possesses a NC value of 2.65 after 14 % of the intermediate 
MgO has been taken into account as a former. 
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Figure 2.5: In the Na2O-CaO-SiO2 system, there is a clear trend of decreasing formation of new bone to 
increasing network connectivity. Data from S. Fujibayashi et al.(2003)
49
 
Data from Fujibayashi et al. supported Eden's observations (Figure 2.5). The figure indicates 
that there is decreasing bone formation at the implant site as the network connectivity of a 
system increases, although Fujibayashi et al.'s trend tended to be more linear despite also 
using glass compositions containing no intermediate oxides in their study. 
 
2.7  Role of components in bioactive glasses 
Bioactive glass compositions are tailored with different components to fulfil their particular 
purpose, whether it's for a prosthetic coating, where both the glass and the implant's 
thermal coefficients of expansion have to match, or for a porous scaffold, where the 
sintering window has to be large enough for it to sinter properly without crystallising.  
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The sintering window is the range of temperatures in which a glass can be sintered without 
the onset of crystallisation occurring, and can be expanded by adding more components to 
the glass. It is defined in Equation 2.4 
Sintering Window = Tc - Tg 
(2.4) 
Where Tc is the crystallisation temperature and Tg is the glass transition temperature of the 
glass system. 
 
The unifying property across all bioactive glasses is that their dissolution products are 
beneficial to the body while promoting bone growth. A large number of components are 
utilised, the foremost of which is silica. Silica is the primary network former used in most 
bioactive glasses. Not only does it hold the structure together, it has also been found that it 
contributes to bone mineralisation as well as activating osteoblastic genes50. Phosphate is 
present to enhance the formation of HCA, whilst at the same time it is used to bring down 
the local pH from glass dissolution. It has also been found that the strength of the interface 
between the implanted glass and bone decreases in compositions without phosphorus51.  
Ca2+ ions are essential in promoting the formation of HCA while at the same time lowering 
the network connectivity of the composition since it is a network modifier. Na+ and K+ also 
play a similar role in reducing the NC and thus the viscosity of the melt.  
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Strontium ions, Sr2+, are similar to calcium ions in that they contribute to HCA formation, 
but have also been found to promote osteoblastic activity while at the same time inhibiting 
osteoclastic activity52. It is often used to substitute calcium since they're both divalent ions, 
however Fredholm et al. has found that ion dissolution in strontium containing glasses is 
faster than that in calcium containing glasses despite the fact that they both share the same 
network connectivity53. This is because strontium's ionic radius is larger and so as a result 
the network as a whole becomes weaker. An added benefit of strontium is that it is radio-
opaque, which assists in post-operative imaging identification of the implant site through 
techniques such as X-ray tomography. Both the intermediate oxides, magnesium and zinc, 
are present to increase the sintering window of the composition. Mg2+ ions have an impact 
on the dissolution rate54 and on the thickness of the HCA layer formed55, while Zn2+ ions 
have been found to enhance the composition's bone regeneration abilities56. It has also 
been found in polyalkenoate cement systems, a cement made from a glass chelating with a 
polymer, that Zn2+ gave rise to antibacterial properties in the resulting cement57. A possible 
problem with including zinc in bioactive glasses however is that it has the potential to be 
cytotoxic to osbteoblastic cells in high concentrations58. In cell culture studies utilising zinc 
containing Bioglass compositions, it was found that the dissolution product exhibited a 
cytotoxic effect on cells above a zinc concentration of 5 mol%.  
 
While the general properties of a glass composition can be estimated by the simple process 
of examining its composition, they cannot be pin-pointed. This is due to the fact that the 
mixing of different oxides gave rise to non-linear properties, which is termed the Mixed 
Alkali Effect59. 
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The presence of mixed alkali in the glass also increases their chemical durability to an 
appreciable degree60, so bioactivity in bioactive glass may be reduced from that predicted 
by network connectivity calculations. However the effect may not be significant at low silica 
contents. 
 
2.8 Porous scaffolds  
Many methods are available from which a porous scaffold can be made. The benefits and 
drawbacks of some of the main methods investigated are detailed below:  
 
2.8.1 Porogen Burn out 
The porogen burn out process is a simple method that involves mixing the glass powder 
with a polymeric space holder in the form of PMMA or gelatin spheres and adding them to a 
wetting solution to create a compact form. The filler spheres are often microbeads with 
diameters of 200-300 µm to simulate the pore size found in natural bone. The organic filler 
is then burnt out under high temperature and the glass is sintered. A prevalent problem is 
that the pores are not homogenous in distribution, leading to regions of closed pores with 
no interconnectivity61.  
 
2.8.2   Sol-gel processing 
The sol-gel approach involves the formation of a gel from a colloidal sol of alkoxide 
precursors, obtained through a series of hydrolysis and polycondensation reactions. The 
typical chemical used to form the basis of the glass network would be tetrathyl orthosilicate  
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(TEOS). The gel is then thermally strengthened, dried to drive off excess water and sintered 
to produce the scaffold material62,63. Scaffolds with interconnects in excess of 100 µm 
(pores 300-600 µm) and porosities in excess of 80% had strengths of 2.4 MPa in 
compression64. 
 
Sol gel scaffolds possess an extremely high surface area (and porosity) for its volume due to 
the fact that it is mesoporous, that is, the whole structure is covered with nano-scaled pores. 
This increase in surface area allows for a much increased rate of dissolution and as a result 
sol-gels are more bioactive than a melt derived glass of similar composition.     
 
The same trait that makes sol gel glasses more bioactive is also the one that raises concern, 
since the dissolution rate of its scaffolds may simply be too fast, leading to mechanical 
failure as it degrades faster than the ingrowth of bone.   
 
The compositions of sol-gels, such as 70 SiO2 - 30 CaO mol %, at first glance seems to have a 
much higher network connectivity than other bioactive melt-derived glasses. 1H MAS-NMR 
studies undertaken by Lin et al.65   however showed that there were extra protons 
associated with each silica tetrahedron in sol-gel glasses from residual hydrolysis. O’Donnell 
suggests that these protons may act as network modifiers, similar to NaO, and thus 
effectively lower the network connectivity to a level similar to that of Bioglass on an 
analogous level 66. Figure 2.6a shows an example of a sol-gel scaffold, while Figure 2.6b 
shows an x-ray micro-CT image of a sol-gel scaffold. 
        37 
 
Figure 2.6: Sol-gel foam scaffolds; (a) photograph courtesy of Dr JR Jones, scale bar is 4 mm; (b) X-ray micro-
CT image courtesy of Dr Sheng Yue, scale bar is 500 µm. 
 
2.8.3  Slip cast foaming technique 
Slip casting is an industrial technique used to mass produce clay products, where a mixture 
of clay and water is placed into a plaster mould before firing. It is useful in that complex 
shapes can be achieved quite easily. 
 
The technique has been modified to produce porous foamed samples, where a slurry of the 
bioactive glass or ceramic is foamed before being placed into the mould to dry, followed by 
firing to produce a porous scaffold. The method has been conducted by Cyster et al.67 and 
Fu et al.68, who both produced porous scaffolds from it. Cyster et al. used sHA powder and 
found that the scaffolds produced displayed excellent interconnectivity (Figure 2.7) with 
pore sizes in the ideal range, although the compressive strengths were only on the region of 
1.0-1.8 MPa. The porosity of the sample is largely dependent on the concentration of 
dispersant (surfactant) within the slip, and to achieve its porosity of 85 % it meant that there 
was an excess amount of dispersant, leading to partial collapse of the foam in each sample. 
(a) (b)
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Figure 2.7: SEM image of pores and interconnectivity in a scaffold made from HA utilising the slip cast 
foaming method, modified from Cyster et al. 
67
. Scale bar is 500 µm.
 
 
Fu et al. used the glass composition 13-93 to produce his scaffolds 68. 13-93 is one of the 
first melt-derived bioactive glasses tailored to overcome Bioglass's susceptibility to 
crystallisation during sintering by expanding its sintering window69 (Section 2.7). In contrast 
to the scaffolds produced using Bioglass73, the sintered scaffold did not crystallise. 
Bioactivity testing showed that crystallised HA formed on the surface of the samples after 7 
days of immersion in SBF (simulated body fluid) despite its higher NC value of 2.59. The 
compressive strengths obtained were much higher than HA, averaging 22 MPa for scaffolds 
with a porosity of 40-45%. While the high strength implies the scaffold was well sintered, 
the higher value is also due to the low porosity and which means that the struts in the 
scaffolds would be thick.  
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2.8.4  Polymer foam replication 
A polymeric sponge with a defined pore structure is impregnated in a ceramic slurry, 
squeezed to remove any excess material and allowed to dry. The sample is then placed into 
a furnace at high temperature to both remove the organic polymer template and to sinter 
the ceramic slurry, leaving a porous scaffold. The advantage of this technique is that 
scaffolds with a set pore size, pore homogeneity and high interconnectivity can be 
obtained70,71,72. Fu et al. used the 13-93 composition to produce amorphous glass scaffolds37. 
The drawback to this method however is that the scaffold's mechanical property will not be 
as high as those made using other methods. This is due to the fact that the scaffolds suffer 
from not possessing fully dense struts.  The slurry may not be able to penetrate fully into 
the foam and as a result voids are created in the centre of each strut (Figure 2.8). The 
problem was exacerbated by experiments where compositions (e.g. 45S5 Bioglass) that 
sinter into glass-ceramics were used, since the glass crystallised before flow between 
particles was complete, leaving voids and micropores behind. Chen et al. synthesized such 
glass-ceramic scaffolds with the 45S5 composition, and the highest compressive strength 
achieved was 0.3-0.4 MPa, for a porosity of 90%, which is unsuitable for load bearing 
applications 73. Another problem associated with the polymer foam replication process is 
that any excess slurry left over from the impregnation will cause pores to close up and 
become blocked, lowering the interconnectivity and porosity of the sample.   
 
Rahman et al. succeeded in creating bioactive glass scaffolds without crystallisation 
occurring using the composition SBP-1 (44.50 mol% SiO2, 4.00 mol% Na2O, 16.30 mol% CaO, 
16.30 mol% SrO, 4.00 mol% K2O, 7.50 mol% MgO, 3.00 mol% ZnO, 4.50 mol% P2O5)
74. 
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However, the hollow struts were still present and problems were encountered during the 
slurry impregnation step, leading to reduced scaffold porosity where the slurry remained in 
the pores even after vacuum suction. This can be avoided by using a foaming process, such 
as the gel-cast foaming process. 
 
 
Figure 2.8: Hollow struts from polymer foam replication, modified from Rahman et al.
74
   
 
2.8.5 3-D printing 
A technique that is becoming popular for scaffold production is 3-D printing, also known as 
additive manufacturing. While there are many different types of additive manufacturing, 
they are all based on layer-by-layer deposition. The technique of robocasting lays down lines 
of viscous polymer containing bioactive glass particles. While the technique has great 
potential, it is time consuming and machines that have the control necessary for printing 
high resolution scaffolds are expensive and it is difficult to produce complex pore networks 
such as those found in trabecular bone. An advantage of producing 3-D grid-like scaffolds is 
that scaffolds with very high compressive strength in the range of cortical bone can be 
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produced (136 MPa with 60% porosity)75, due to the thick strut size and accurate alignment 
that can be obtained. 
 
Figure 2.9: X-ray micro CT image of a robocast bioactive glass scaffold modified from Bio-glasses: An 
Introduction (Jones and Clare 2012)
76
. Scale bar is 500 µm. 
 
2.8.6 Gel-casting of ceramics   
Gel-casting was originally a method developed by Omatete and Janney et al. in the 90s77,78 
to produce dense ceramic foams. The process is similar to slip casting where the slurry is still  
poured into a mould, but a monomer system is used to hold the slurry in place through an in 
situ polymerisation reaction such that the desired structure is retained in the final product.  
 
To begin with, a multifunctional monomer is dissolved in a solvent and mixed with the 
ceramic powder. Since most ceramics are unaffected by water, water-soluble monomer 
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systems such as acrylates are used, a specific example being acrylamide 77,79. The problem 
with just using acrylamide is that it will form a linear polymer upon polymerisation, giving a 
low capacity to retain the desired structure and resistance to green body machining. To 
increase this, a cross-linker is added so that a branched polymer is formed. N,N’ – 
methylene bisacrylamide is often used80. Acrylamide was found to be neurotoxic however 
and so it was replaced with the safer methylacrylamide80.   
 
The system polymerises through a free radical addition reaction so an initiator is needed in 
the process. For the methylacrylamide system ammonium persulphate (APS) is used, where 
the molecule splits along a single bond into two radicals to initiate the polymerisation 
reaction. In order to speed up the process a catalyst is added, which is N,N,N’,N’-
tetramethylethylene diamine (TEMED). The in situ polymerisation is relatively quick, and 
eliminates the lengthy forming times and density variations associated with industrial slip 
casting processes77.  
 
The resulting green body is then dried to remove the solvent and placed into a furnace to 
burn out the organic content as well as sintering the particles together. This process was 
then adapted by Verma et al.81 to produce dense HA monoliths, who found that the porosity 
and microstructure of the samples were highly consistent. Sepulveda et al. took the process 
further and introduced a foaming step, giving rise to porous gel-cast alumina82,83 and sHA 
(synthetic hydroxyapatite)84,85. To create the porous scaffolds, the slurry was vigorously agitated 
with the aid of the surfactant Tergitol TMN10 as the in situ polymerisation reaction occurs. The 
presence of the surfactant lowers the surface tension of the slurry and allows the foam 
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structure to be maintained as the system gels. It was found that the amount of foam body was 
heavily influenced by the surfactant, which in turn dictates the final porosity of the sample.  Just 
before the gel completely sets, it was poured into moulds before the regular procedures of 
drying and sintering begins (Figure 6).    
 
 
Figure 2.10: Flow diagram of the gel-cast foaming process, modified from Sepulveda, 1999
82 
 
The time between the addition of the reagents and the beginning of polymerisation is 
known as the induction period. The length of this period affects the pore morphology of the 
foam as a result of the ongoing bubble enlargement and lamellae thinning with time, 
leading to larger pore sizes82,83. Too long an induction time would lead to foam collapse86. It 
was noted however that interconnect size did not vary much even when samples with 
induction time 90s and 200s were compared under SEM examination.  
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The foam body volume determines the porosity of the structure, while the induction time 
influences the pore size. These are the key two factors influencing the main morphology of 
the sample. Young et al. found that the induction period can be reduced by increasing the 
amount of initiator and catalyst used, as well as increasing the temperature87.  The 
surfactant used also has an influence on the microstructure of the foam as found by Fuji et 
al.88. In the study, mining and industrial waste such as low grade alumina were the raw 
materials used. It was found that the anionic surfactant ammonium lauryl sulphate gave a 
higher open-pore porosity and hence lower density than the non-anionic surfactants. It also 
gave rise to a higher pore size distribution however.  
 
Some inherent problems with the addition of the drying step to the gel-casting process was 
that the polymerisation kinetics of the system would change, giving a lower reaction rate 
and a higher sensitivity to temperature83. In addition, the green bodies were also more 
prone to cracking during the drying stage, although it could be mitigated somewhat by 
introducing a plasticiser89,90. 
 
Overall, the gel-cast foaming process is suitable for adaptation to bioactive glass 
compositions as opposed to ceramics- it produces highly homogenous samples with fully 
densified struts, giving it a higher compressive strength compared to the polymer foam 
replication method. The green bodies take a shorter time to dry compared to slip casting, 
for example it can take as little as 10 hours, compared to days for slip casting;  and the in 
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situ polymerisation reaction means that the foam structure of the green body is retained, 
leading to a high porosity with open pores and regular interconnect sizes.  
 
2.8.7  Gel-cast foaming of bioactive glasses 
The challenge in using bioactive glass compositions as opposed to ceramics was to modify 
the process for glasses and to determine glass compositions that could be used in the 
process without crystallising. The main challenges are: 
i) using a composition that will not crystallise or react with water, and yet is still 
bioactive 
ii) identifying a gelation mechanism and optimising the many variables 
Wu et al. identified a process using the glass compositions ICIE16 (49.46 mol% SiO2, 6.60 
mol% Na2O, 36.27 mol% CaO, 6.60 mol% K2O, 1.07 mol% P2O5) and ICIE16M (49.46 mol% 
SiO2, 6.60 mol% Na2O, 27.27 mol% CaO, 3.00 mol% SrO, 6.60 mol% K2O, 3.00 mol% MgO, 
3.00 mol% ZnO, 1.07 mol% P2O5)
6,47. The sintering temperature had to be carefully 
considered since too high a temperature caused unwanted crystallisation of the sample, 
while the glass will not sinter a temperature below its Tg. DSC was performed on the 
compositions to determine the optimal sintering temperature. However, the deionised 
water that was used to make the glass slurry reduced the Tc of the glass such that the 
optimal sintering temperature was lower than what the DSC traces predicted. The Tc 
reduced by 25 to 50 °C, depending on the composition of the glass6. The decrease was likely 
to be caused by the increased mobility of ions such as Na+ in an aqueous environment. This 
would cause crystalline phases to form at lower temperature, due to a lower activation 
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energy for crystallisation.  Another factor that affected the Tc of the glass was the particle 
size, where it decreased with decreasing particle size. However, a small particle size was also 
needed for efficient sintering, as driving force for sintering increases as particle size 
decreases. Another side effect of using water in the slurry was that the sodium potassium 
sulphate crystals formed on the glass during the thermal processing. This was attributed to 
the water causing glass dissolution (leaching of cations) which reacted with the sulphate 
from the initiator (ammonium persulphate). Water is necessary if a surfactant is to be used 
to foam the slurry. The gelation time was short (2 minutes or less) therefore it was during 
the slow drying process that the formation of sodium potassium sulphate occurred. 
Therefore the drying temperature was increased to 125°C and the holding time increased to 
10 h. The effect of reducing initiator content was also investigated. Minimising the initiator 
was successful in reducing the formation of sodium potassium sulphate, as was increasing 
the drying temperature, however increasing the drying temperature was also found to 
reduce Tc . Surprisingly, the more simple ICIE16 composition sintered more efficiently than 
ICIE16M. Wu et al. therefore optimised the processing parameters for the ICIE16 and 
ICIE16M compositions, which was a starting point for this work (Section 3.4). However 
sodium potassium sulphate crystals were still present in small concentrations. Although the 
crystals may be biocompatible, sintering efficiency was not ideal and they changed the 
surface topography. Therefore an aim of this work was to identify new compositions with 
reduced Na and K but the same network connectivity. 
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An example of a scaffold produced via the gel-cast foaming method can be seen in Figure 
2.11, displaying pores between 200-300 µm.  
 
Figure 2.11: Figure X-ray micro-CT image of the gel-gal ICIE16 glass scaffold made by gel cast foaming. 
Modified from Wu et al.
6
 Scale bar is 500 µm. 
 
An EDX scan of the sample (Figure 2.12) shows that an abundance of sulphur, sodium and 
potassium were present, suggesting the presence of sodium potassium sulphate crystals on 
the scaffold surface. The sulphur was likely sourced from the initiator used (ammonium 
persulphate) and the sodium and potassium from ions leached from the glass composition.  
To gain familiarisation of the gel-cast foaming technique, a preliminary study with ICIE16 
and ICIE16M was conducted and scaffolds with similar characteristics to that developed by 
Wu et al. were produced. SEM and EDX were performed and the same crystalline structures 
could be seen on the glass surface. To verify that the small structures were in fact a by-
product of the initiator, an XRD scan was taken (Figure 2.13). 
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Figure 2.12: EDX spectrum showing presence of sodium potassium sulphates in the ICIE16M sample above. 
Courtesy of Wu et al. 
 
 
Figure 2.13: XRD trace of an ICIE16M scaffold. The marked peaks are indicative of potassium sulphate. 
The prominent peaks in Figure 2.13 corresponds to that of potassium sulphate (reference 
code 00-044-1414), confirming the results from Wu et al.6 and from the SEM.  
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2.9 Objectives 
The objective of this study is to produce bioactive glass scaffolds with highly interconnected 
pore structures that do not undergo crystallisation during sintering, investigating the effect 
of changing the glass composition on the structure and properties of scaffolds produced by 
the gel-cast foaming process. By changing the glass composition the surface chemistry and 
charge interactions between the glass and the surfactant will change, leading to a different 
foaming result and a need to adjust processing variables. Since the effect of the sodium 
potassium sulphate crystals has on the overall properties of the scaffold is still unclear, the 
secondary aim of the investigation is to eliminate the surface crystals' formation. 
 
As part of a project with the Technology Strategy Board, some of the scaffolds produced 
would be sent for an ovine in vivo study, where they would be implanted in the same format 
as other currently marketed bioactive glass bone grafts. As such, the samples would need to 
withstand crushing into granule form (3-5 mm across) for implantation without breaking 
apart into powder. This requires the samples to be as sintered as possible and thus the 
sintering regime has to be carefully optimised. 
 
To achieve these aims, the study will involve scaffold processing, characterisation, 
bioactivity testing and provision of samples for cell culture analysis. 
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3 Glass compositions, preparation and characterisation 
methods 
 
3.1 Glass compositions 
A variety of glass compositions were investigated in this study. Since a preliminary study was 
undertaken to achieve results comparable to Wu et al.'s scaffolds, ICIE16 and ICIE16M were 
made. The main focus of this study was on the glass composition SBP-1 and subsequently 
SBP-3. To be able to determine and compare the influence of strontium in a glass, SBP-2 was 
made. It had the same composition as SBP-1, with the difference that its strontium content 
was replaced by another element in Group II of the periodic table: calcium. Once the 
emphasis of the study switched to SBP-3 instead due to the undesirable effect that zinc had 
in an in vitro cell study in Section 4.2, a comparison glass (SBP-4) was produced to once 
again compare a glass system with and without strontium content.  Bioglass 45S5 and 13-93 
were also produced as a basis of comparison - the former as it is the standard most 
bioactive glass compositions compare to, and the latter as it is the most commonly used 
melt-derived composition in scaffold synthesis. 
 
The particular components of each glass composition are listed in Table 3.1. 
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 Table 3-1: Compositions of the investigated glasses in mol%, NC refers to the network connectivity if the 
intermediate oxides are acting as network modifiers, NC' if they are acting as formers.  
 
Based on an x-ray fluorescence study on the composition SBP-3 (Section 4.4), the 
compositions were made to an accuracy of 95%.  
 
3.2 Glass production and processing 
The glasses were made via the melt-quenching route, where the precursor oxides [calcium 
carbonate (95% pure, Sigma Aldrich), silica (High Purity, Prince minerals, Stoke-on-Trent), 
magnesium oxide (≥98%, Sigma Aldrich), sodium carbonate (≥99.5%, Sigma Aldrich), calcium 
phosphate (≥96%, Sigma Aldrich), strontium carbonate (≥98%, Sigma Aldrich), potassium 
carbonate (≥98%, Sigma Aldrich)] were mixed in a container in quantities according to their 
mole percentage and poured into a platinum crucible. The crucible is then placed into a 
furnace and held at 1200 °C for two hours. 13-93 required a higher melt temperature and 
  SiO2 Na2O CaO SrO K2O MgO ZnO P2O5 NC NC' 
ICIE16 49.46 6.60 36.27 0.00 6.60 0.00 0.00 1.07 2.13 2.13 
ICIE16M 
 
49.46 
 
6.60 
 
27.27 
 
3.00 
 
6.60 
 
3.00 
 
3.00 
 
1.07 
 
2.13 
 
2.55 
 
SBP-1 44.50 4.00 16.30 16.30 4.00 7.50 3.00 4.50 2.31 3.01 
SBP-2 44.50 4.00 32.60 0.00 4.00 7.50 3.00 4.50 2.31 3.01 
SBP-3 44.50 4.00 17.80 17.80 4.00 7.50 0.00 4.50 2.31 2.84 
SBP-4 44.50 4.00 35.60 0.00 4.00 7.50 0.00 4.50 2.31 2.84 
13-93 54.60 6.00 22.10 0.00 7.90 7.70 0.00 1.70 2.59 3.01 
45S5 46.10 24.40 26.90 0.00 0.00 0.00 0.00 2.50 2.11 2.10 
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the composition was heated at an increased temperature of 1300 °C. After this period, it is 
taken out of the furnace and the glass is poured into a bucket of deionised water for shock 
quenching in order to prevent crystallisation and phase separation.  
 
As a result of the shock quench process, glass frit is produced, which is then dried overnight 
in a pressure oven set at 100°C before being ground by a gyro mill (Glen Creston Gyro Mill, 
Middlesex, England)  for two intervals of seven minutes. The resulting powder will contain a 
large variation in size distribution, and since particle size plays a large part in sintering, the 
glass powder is sieved down to <38µm with the aid of a vibratory mill for one hour.  
 
The SBP compositions differ from the others in that the frit is placed in a jet miller rather 
than a gyro mill, which serves to both grind and ‘sieve’ the powder at the same time. One 
problem that arises with this process is that the resulting powder will contain slightly higher 
concentrations of iron, chromium and nickel from contact with the 316L steel in the walls of 
the vortex chamber, but the increase is such that it should not have been an issue (Table 
3.2).  
 
Table 3-2: Concentrations of iron, chromium and nickel in SBP-1 glass powder before and after jet milling 
(courtesy of CERAM Research). 
 
Level before jet milling Level after jet milling 
 
(ppm) (ppm) 
Iron <50 85 
Chromium <5 20 
Nickel <5 10 
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Another difference with the SBP series was that rather than using the traditional 
phosphorus precursor phosphorus pentoxide (P2O5), the glasses were batched using β-
tricalcium phosphate (Ca3(PO4)2 ). This approach was used since it improved accuracy of the 
batching of oxides prior to melting as it did not react with the atmosphere. In contrast 
phosphorus pentoxide is a powerful desiccant and reacts with atmospheric water as soon as 
it is removed from storage; forming phosphoric acid. The reaction of phosphorus pentoxide 
to water is shown in Equation 3.1. 
                  
(3.1) 
In practice the reaction forms a viscous protective layer that inhibit further reactions. 
Nonetheless, to increase the accuracy of batching, phosphorus pentoxide had to be weighed 
quickly to limit its absorbance of atmospheric water.  
Despite tricalcium phosphate being less reactive, it did however complicate the batching 
process since it also contained calcium. This was accounted for in the calculations by 
subtracting in mole % from calcium oxide three times that used for the phosphorus 
precursor before normalising the mole percentages. The weight % and hence the amount 
needed from each precursor for batching can then be calculated as normal from that.  
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3.3 Particle Sizing 
The glass frit must be ground to small particles. Different grinding techniques produce 
particles of different morphologies and yields. 
 
3.3.1 Jet milling 
A Hosakowa Micron Ltd (Runcorn) jet mill was used in collaboration with CERAM to grind 
the glass to < 38 µm. In a jet mill, the particles are injected into a chamber, which is 
subjected to continual jet of high pressure air.  The particles collide with each other, 
reducing particles size. The lack of milling media should mean less contamination compared 
to other methods. Sieving not needed due to the use of a classifier. A classifier is a stainless 
steel grid around the chamber. As particles became small than 38 µm, they could pass 
through the classifier and be collected.  
 
3.3.2 Gyro-mill 
Due to complications with the jet-milling process (Chapter 4) another grinding method had 
to be utilised. Gyro-milling involves crushing glass frit between hard surfaces arising from a 
circular rotary motion. Glass particle sizes are controlled by the length of grinding time, and 
this is different for varying materials. Once a grinding regime has been established however 
the particle sizes are reproducible for the same material. The grinding container contains a 
ring and a puck (Figure 3.1). Glass frit is placed in the spaces between them and the 
container is secured within the gyro-mill (Glen Creston Ltd). Once the machine starts, a high 
speed rotary motion is applied on the container, resulting in the glass frit being crushed 
        55 
against the sides of the container, ring and puck. The glass particles produced are angular in 
shape due to this high energy crushing91.  
 
Figure 3.1: a) Diagram of a grinding container at rest, showing glass frit placed between the spaces of the 
container, ring and puck. b) Diagram of a Gyro-mill in use, showing the high speed rotary motion of the 
machine inducing the ring and the puck to gyrate against each other and ring against the container. This 
causes areas of attrition where glass frit is crushed into glass powder. 
To attain particle sizes similar to that from jet milling, the glass powder was sieved via sieve 
with ultrasonic deblinding (Russell Finex Ltd, Feltham). In this case the smallest sieve was     
< 32 µm. 
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3.4 Gel- casting 
The aim of the gel-casting process is to produce a porous scaffold without the use of a 
template. A glass slurry is foamed with the use of a surfactant and gelled by the in situ 
curing of a polymer gelling agent. The polymer binds the particles and is removed by 
thermal decomposition immediately prior to sintering. Figure 3.2 shows a flow chart of the 
process. The protocol devised by Wu et al. was used as a starting point.6 
 
 
Figure 3.2: Flow diagram of the gel-cast process  
 
The initiator was made first to allow it to dissolve properly in solution: 13 g of ammonium 
persulphate (Sigma Aldrich, 98+ %) was taken and added to 25 ml of deionised water 
(concentration 0.52 g/ml).  
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20 g of the glass powder was placed into a 250 ml polypropylene beaker and to that was 
added 6 g of the monomer methacrylamide  (Fluka, >98%). The powders were gently 
agitated to ensure mixing occurred. 3 g of the crosslinker N,N’-methylenebisacrylamide 
(Sigma Aldrich, >98%) was added, ensuring the container was agitated each time a new 
component was placed in. Deionised water (18 ml) was poured in to act as the solvent for 
the system and 2 drops of the dispersant Dispex were added to ensure that all the 
components were mixed homogenously, followed by 0.1 ml of Triton X-100, the surfactant 
used to create the pores. 
 
To start the polymerisation reaction, 2 ml of the initiator was added, followed by 4 ml of the 
catalyst TEMED (N,N,N’,N’-Tetramethylethylenediamine, Sigma Aldrich, 99%). The system 
was then vigorously agitated via the use of an electronic whisk (Kenwood, speed setting 1), 
with the viscosity of the slurry increasing as the polymer begins to gel. Eventually the 
sample's viscosity is such that it did not flow anymore, which is known as its point of 
gelation. Two to three seconds before the complete gelation of the polymer, defined as the 
pouring window where its onset of viscosity increases, the foam was poured into moulds 
and placed into an oven to dry (125 °C, 10h). The samples were then taken out of the oven 
and placed into a furnace for polymer burn out (350 °C, 1h) followed by sintering for one 
hour at 700 °C. 
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The main variable investigated in this work was the effect of changing the glass composition 
Table 3.1) on the structure and properties of the scaffolds produced by the gel-casting 
process. The composition had an effect on the processing variables, so they were adjusted 
appropriately (see results – Sections 4.3 and 5.5). One of the most important was the final 
sintering temperature. 
 
3.5 Characterisation Techniques  
A range of techniques was used in this study, below are brief descriptions concerning each 
one.  
 
3.5.1 Differential scanning calorimetry (DSC) 
DSC is a thermal analysis technique that provides data on the thermal behaviour of the 
sample placed within it by measuring the input of heat required to maintain the sample and 
the reference material’s temperatures constant over a range of predefined temperatures. 
Since both the sample and the reference are maintained at the same temperature, and the 
heat capacity of the reference is known for the range of temperature scanned, a graph can 
be plotted with the inflow of heat against temperature (Fig. 3.3), showing data such as the 
sample’s glass transition temperature and peak crystallisation temperature.  
 
The glass transition temperature can be obtained in this fashion by looking for a flat dip in 
the flow of heat to the sample to maintain the constant temperature between it and the 
reference, since it is an endothermic process. The crystallisation temperature is obtained by 
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searching for the highest peak on the graph, since the change from amorphous to crystalline 
solid is exothermic. A summary of the common processes that occur is shown below: 
 
 
Figure 3.3: Common features in a DSC trace 
 
3.5.2 SEM 
Scanning electron microscopy is an imaging technique that utilises an electron probe to 
garner information on the surface of the specimen through the detection of secondary or 
backscattered electrons. In secondary electron mode, the contrast is on the topological 
nature of the specimen, while the detection of back-scattered electrons allows for contrast 
between differing compositions92. In this study only secondary electron imaging was used. 
The microscope JEOL-6400 is also be fitted with an Energy Dispersive X-ray spectrometer 
(EDX), which allows for the compositional analysis of a small section of the sample at an 
elemental level. The problem with SEM imaging is that it is a destructive technique, since 
the glasses are non conducting and must be coated, rendering the samples redundant to 
further analysis. 
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3.5.3 MIP 
Mercury intrusion porosimetry is technique used to identify the interconnect size 
distribution of a porous material. Under vacuum, mercury is forced into the pores of the 
sample at an increasing pressure, in competition with the resistive force due to surface 
tension of the mercury. The pressure values are then applied to the Washburn equation to 
determine the interconnect sizes present within the sample93. The Washburn equation does 
however assume the interconnects to be cylindrical, which may not be representative to 
those in the sample. Another issue with this technique is that it is a destructive technique 
since mercury is a cumulative poison that cannot be expelled by the body once absorbed 
and is highly toxic. 
  
3.5.4 XRD 
X-ray diffraction is a technique that utilises x-rays to determine the crystal or lattice 
structure of a material, such as the interplanar spacing or the crystallite thickness. The x-
rays emitted by the machine, produced via the process of accelerated electrons striking a 
metal target, are diffracted by the crystalline parts of the material according to Bragg’s Law 
(Equation 3.2). 
 
nλ = 2d sinθ 
(3.2) 
 
where: λ= wavelength of incident beam 
 d= interplanar spacing 
θ= angle between incident beam and scattering planes 
n= an integer 
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The x-ray emitter is made to traverse a range of angles, usually between 10 and 80°2θ, to 
target the sample and these diffracted rays are then picked up by a detector, which then 
plots the intensity of the diffracted rays as a function of the angle 2θ. 
 
From these resolved peaks much information can be gained regarding the compositional 
and inter-atomic structure of the sample, such as its unit cell dimension or chemical 
composition. In the case for this study, the method is only used to determine if the glass 
scaffold has crystallised, since this would drastically reduce its bioactivity. Instead of clear 
resolved peaks expected from a purely crystalline material, an amorphous material 
containing some crystalline phases would exhibit a noisy amorphous band with broad peaks. 
 
 
3.5.5 Particle Size Analyser 
The particle size distribution of particles in a suspension was measured using the light 
scattering technique on a Malvern Mastersizer. Particle size can be measured provided the 
refractive indices of the glass and the dispersion medium (water) are not the same. The 
principle of light scattering is that any particle, regardless of size, scatters light in all 
directions. In small particles this distribution is quite even, with light scattered at large 
angles, but the larger the particle, the larger the forward scatter component will be. This 
leads to smaller scattering angles with light of higher intensities. The intensity levels of the 
light are measured by two separate photodiodes: the central detector, which measures the 
intensity of the unscattered light and the main detector, which measures the intensity of 
the scattered light94, as shown in Figure 3.4: 
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Figure 3.4: Conventional Fourier optics setup in a laser scattering particle analyser, modified from The 
Mastersizer Micro and Microplus User Manual 
 
By measuring the intensity of the unscattered light via the central detector, and comparing 
it with the power input for the laser, the sample volume concentration can be calculated. 
The input on the main detector from the light scattered by the batch of particles is 
measured and transformed by an implementation of Mie Theory95 to give the particle size 
distribution of the suspension. It should be noted that this model assumes that all particles 
can be approximated as perfect spheres, which may not always be the case: for instance 
particles ground by gyro mills tend to have an angular morphology91.  Another point to take 
into account is that the distribution given is volume based. This means that the larger the 
difference between particle sizes, the larger the influence that the large particles have on 
the measured particle size distribution over the smaller ones96.  
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3.5.6 X-ray microtomography  
X-ray microtomography (µCT) is a non-destructive imaging technique that can be used to 
obtain detailed structural details of porous scaffolds in 3D97. It achieves this by taking a 
series of cross-section 2D images as the sample is rotated. The 2D slices are then 
reconstructed into a 3D image. With further processing and application of algorithms, it is 
also possible to calculate the interconnect size and pore size of the sample98. This technique 
images samples via X-ray attenuation, which depends on the material’s density.  
 
The intensity of the voxels (3D pixels) relate to the density of the regions within each of the 
voxels. Here, cubic glass scaffolds with approximately 5 mm dimensions were imaged using 
a using a lab-based μCT unit (Phoenix X-ray Systems and Services GmbH, Wunstorf, 
Germany) at 100 kV and 100 μA, and with a voxel size of 7 µm. The resolution is determined 
by voxel (3D pixel) size. Scans and image analysis was carried out by Dr Sheng Yue and 
Professor Peter Lee, now at the University of Manchester. 
 
3.5.7 Helium Pycnometry 
A helium pycnometer is used to deduce the skeletal density of a material. The volume of a 
given sample is measured by comparing the relative volumes filled by the same amount of 
ideal gas between two chambers, the reference chamber and the sample chamber99. The 
pressure differential between the two chambers is measured through a pressure transducer 
and the ideal gas laws are applied. The relationship of the variables in the two chambers is 
given by the following equation: 
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(3.3) 
Where P1 is the pressure in the reference chamber, V1 is the volume of the reference 
chamber, and T1 is the temperature of the reference chamber. P2, V2 and T2 are the pressure, 
volume and temperature of the sample chamber respectively. Since the temperature in 
both chambers is kept constant through a water bath, the T values can be dropped from the 
equation. 
 
From this, the sample density can be measured by the simple equation of sample mass 
divided by its volume. The mass of the sample was measured using a balance. Glass rods 
were made by pouring the molten glass from its platinium crucible into a graphite mould 
and annealing the cast glass at 350 °C. The pycnometer was set to measure values until 20 
runs were performed for each sample, or three concurrent runs with values within a 
standard deviation of 0.003 were obtained, whichever came earlier. The experiment was 
performed three times and averaged. 
 
3.5.8 Simulated Body Fluid Testing  
To gain an understanding of the bioactivity of the glass compositions, a process devised by 
Kokubo was used100. SBF (simulated body fluid) testing involves immersing the samples in a 
fluid comparable to that of human blood plasma in terms of ion concentration, with the 
sample amount in the ratio of 150 mg to 100 ml of SBF. When bioactive materials are 
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immersed in SBF, their dissolution products should leach and HCA should deposit on the 
surface of the material. The samples were left in the SBF for three weeks. At each time point 
(4h, 8h, 24h, 72h, 1, 2 and 3 weeks) 1 ml of SBF was removed for analysis and replaced with 1 ml 
of fresh SBF.  Ionic concentrations for each of the glass components (Sr, Zn, Mg, K, Na, Si, Ca 
and P) were measured using ICP-AES (inductively coupled plasma-atomic emission 
spectroscopy). Prior to analysis the 1 ml samples were diluted 1 in 100 and some of the 
solution was used to measure Sr, Zn, Mg, K, Si, Ca and P content. The rest of the 1 in 100 
solution was then diluted again to make a solution of 1 in 1000 dilution so that Na could be 
measured. To detect HCA formation, after the three weeks of immersion the samples were 
dried and then analysed by FTIR (Fourier transform infra-red) spectroscopy and XRD.  
 
3.5.9 Inductive Coupled Plasma Atomic Emission Spectroscopy 
ICP-OES is a technique used to determine the elemental concentrations within a solution. 
The solution has to be diluted first so as to not overwhelm the detector. It is then passed 
through a nebuliser to turn it into fine droplets before entering the plasma chamber where 
it is ionised. When the electrons in the ions return to their lower energy state, light is 
emitted at a wavelength specific to each element and detected by an optical emission 
spectrometer. The intensity for each element is measured. They are then compared to a 
calibration curve for each specific element and thus the precise concentration of elements 
within the solution can be determined. 
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3.5.10 Nuclear Magnetic Resonance 
This technique is used to determine the structure of a particular material by providing 
information on the coordination numbers of a particular atomic species as well as the 
number and type of neighbours that it has.  
 
In general, an atom is composed of a nucleus and the electrons that occupy potential wells 
around it, attracted by the protons’ electrostatic force. Associated with each atomic nucleus 
is their nuclear spin (I), with values ranging from 0 and up in increments of ½, with units in 
terms of h/2π 101. The nucleus’ spin is determined by its mass and atomic number. Nuclei 
that have even mass numbers and odd atomic numbers will have a nuclear spin that is an 
integer, while those with odd mass numbers and even or odd atomic numbers will have 
nuclear spins in denominations of ½. Lastly, nuclei that have even numbers for both mass 
and atomic numbers do not have any inherent nuclear spin, with a value of 0. NMR 
techniques will therefore not be able to operate on these atomic species, as explained 
below.  
 
Normally, the energy of the nucleus is in one state, but when it is exposed to a magnetic 
field several sub-states can emerge, with energies slightly above or below that of the rest 
state102. This phenomenon is termed the Zeeman Effect. The number of sub-states that 
appear is equal to 2I+1, which is why nuclei with 0 nuclear spin will not split into energy sub-
states. Fig. 3.5 shows a diagram of the Zeeman Effect. 
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Figure 3.5: The Zeeman Effect for nuclei with nuclear spin of ½ 
 
An important note to add is that the lower energy sub-state will contain slightly more nuclei 
compared to that of the higher energy sub-state, a consequence of the laws of 
thermodynamics103. 
 
This is not the only restriction on what can be analysed by NMR spectroscopy. A second 
criterion the sample has to fulfil is that it must have a high natural abundance of the isotope 
being scanned for, or the detector will return proportionately lower readings.  
 
In the magnetic field, the nuclei in the lower energy sub-state will start to precess around 
the axis of the magnetic field, and when the resonant frequency for that particular nucleus 
reaches it, it will be absorbed by the nucleus, thus exciting it to the higher energy sub-state. 
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The most common method used in solid-state NMR to provide the desired spectrum is the 
pulse Fourier transform technique, where the sample is exposed to a constant, fixed 
magnetic field, which induces the Zeeman Effect. Then, a pulsed second field is applied at 
the resonant frequency of the species concerned. The nuclei in the lower levels of the 
energy sub-states will absorb this and rise in energy levels through excitation. When this 
second field switches off, the excited nuclei relax again, releasing the absorbed energies. 
These energies are recorded, Fourier transformed and plotted against the chemical shift.  
 
In order to explain the concept of chemical shift, recall that between the nucleus and the 
applied external field is a cloud of electrons. This means that the field that reaches the 
nucleus is different to the field applied, because the electrons provide ‘nuclear shielding’, 
which is proportional to the applied strength of the external field104. That is, the higher the 
applied field, the higher the nuclear shielding will be. The chemical shift is simply the 
nuclear shielding provided by the electrons divided by the applied field strength.  
 
The chemical shift is entirely dependent on the chemical environment of the molecule 
containing the species being scanned. Therefore factors such as electronegativity will affect 
it.  
 
Since, unlike in a solid, the molecules in a liquid are constantly mobile, there will be a 
difference between the NMR scans of a solid and a solution. Importantly, the fast isotropic 
molecular tumbling which occurs in a liquid prevents magnetic dipolar interactions, 
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anisotropic chemical shift interactions and, for nuclei with nuclear spin greater than ½, 
quadrupolar interactions.  All of these factors cause a loss of resolution through line 
broadening. It is therefore disadvantageous to scan solids when a solution state option is 
available.  When such a state is not practically achievable, the deleterious effects can be 
significantly reduced through the process of magic angle spinning (MAS). Implementing this 
method involves packing the sample powder tightly into a rotor, which is then spun 
between 1 and 35 kHz105 at an angle of 54.74° to the direction of the magnetic field, thereby 
reducing the effects of the dipolar and chemical shift interactions.  
 
Here solid state NMR was used to obtain information about the connectivity of the silica 
network (29Si). 29Si spectra were collected by Dr Robert Law (Department of Chemistry) with 
a magnetic field of 9.4 T at a frequency of 79.45 Hz. 
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4 Reduction of surface crystallisation in the gel cast foaming 
process 
As discussed in Chapter 2, the starting point of this work was that Wu et al.6 had produced 
porous glass scaffolds from ICIE16 and ICIE16M compositions (Table 3.1) with minimal bulk 
crystallinity but potassium sulphate crystals formed on the glass surface, due to the initiator 
reacting with potassium and sodium from the glass. When the glass was in contact with the 
water in the gel-cast foaming process, sodium and potassium ions were released from the 
glass were free to react with the sulphate from the initiator. To eliminate this, the first aim 
was to change the composition of the glass to reduce the sodium and potassium content, 
while preserving a large sintering window and maintaining bioactivity.  
 
Grinding the glasses with the jet-mill produced particles with a D50 of 9.8 µm. The work 
began with a protocol based on Wu et al.’s process (Section 3.4): 20 g of glass powder (< 38 
µm); 6 g of the methacrylamide; 3 g of N,N’-methylenebisacrylamide; 18 ml DI water; 2 
drops of Dispex; followed by 0.1 ml of surfactant (Triton X-100); 2 ml of initiator (ammonium 
persuphate) and 4 ml of the catalyst (TEMED (N,N,N’,N’-Tetramethylethylenediamine). The 
mixture was then subjected to vigorous agitation (foaming). 
 
The Wu et al. procedure also involved pouring the foam into a mould immediately prior to 
gelation. However the gelation point was not consistent and the pouring window was small. 
If the slurry was poured too early, the foam structure would collapse as it cannot hold its 
own weight; if it was poured too late, gelation occurred in the mixing vessel. Another aim 
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was therefore to eliminate the pouring step to improve reproducibility and scalability of the 
process. 
 
4.1 SBP-1 
A new composition was investigated with the SBP-1 composition. Since it contains a lower 
potassium and sodium content compared to ICIE16 and ICIE16M, its tendency to form 
sodium potassium sulphate crystals should be lowered. It also contains a higher amount of 
strontium and phosphorus content, which should increase its bioactivity once in the body 
(section 2.6). With a new composition of glass used, the production process had to be re-
optimised, followed by studies into the most efficient sintering regime in order to produce a 
stable scaffold. Once such scaffolds were produced, they were tested for bioactivity via a 
SBF study and tested for cell viability through an in vitro study. These studies are reported in 
this section. 
 
Initial attempts to create scaffolds using the standard procedure outlined in Section 3.3 
were not successful. This was due to the polymer gelling more rapidly than it did when 
ICIE16 or ICIE16M were used. The gelation was so rapid that it was not possible to pour the 
foam into the moulds. The composition of the glass therefore affected the polymerisation 
mechanism. To increase the gelation time, the amount of the catalyst (TEMED) was lowered 
from 4 ml to 3 ml. The reduction in catalyst allowed the production of foam that could be 
poured into moulds, although the pouring window was still small.  
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The gel-cast foaming method was developed further (Figure 4.1) to address the irregularities 
caused by the pouring process by eliminating the pouring step altogether. The gel was 
allowed to gel in the foaming container. The gelled foam was then removed from the mould 
and cut into the desired shapes. To achieve this, the slurry was vigorously agitated for 90-
100s and the mixing blade was then removed. The green body foam was then allowed to gel 
for 15 minutes before it was removed from the mould and cut into the sample shape and 
dried. Since there was no pouring involved, the problems associated with the pouring step 
were removed.  
 
 
Figure 4.1: Flow diagram of the gel-cast foaming process adapted to remove the pouring step. 
 
Since the new composition affected the process, the sintering regime had to be optimised 
again by sintering samples at different temperatures. While the sintering temperature 
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would usually be determined though thermal analysis, the water in the gel cast foaming 
process affects the Tg and Tc of the glass. Therefore different sintering temperatures were 
investigated. All scaffolds were held at the chosen sintering temperature for one hour and 
produced by the method shown in Figure 4.1.  
 
Sintering at 680°C 
 
Figure 4.2: SEM micrographs of SBP-1 scaffold sintered at 680°C at magnification a) 50x, b)1000x 
 
Figure 4.2 shows SEM images of the SBP-1 scaffolds sintered at 680 °C. Figure 4.2a shows 
that most of the pore sizes within the sample sintered at 680 °C for 1 h were in the range of 
100-500 µm with interconnects. The SEM images give an idea of the pore structure, but a 
combination of mercury porosimetry and X-ray microtomography is needed to fully 
understand and quantify the pore structure. Due to time and resource constraints such 
analyses were reserved for scaffolds that were considered “optimal”.  
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The scaffolds sintered at 690 °C were very fragile, suggesting incomplete sintering. They 
crumbled under manual handling and so would not be suitable for bone graft applications. A 
higher magnification image of the same sample in Figure 4.2b reveals a highly granulated 
surface, where the original angular glass particles could still be seen, indicating that the 
scaffold has not completely sintered, leading to fragility.  
 
Sintering at 690°C 
 
Figure 4.3: SEM micrographs of SBP-1 scaffold sintered at 690°C at magnification a) 50x     b)1000x 
Sintering at 690 °C produced a similar pore structure (Figure 4.3a) and the high 
magnification SEM (Figure 4.3b) also showed individual particles of glass, but the higher 
sintering temperature caused some flow in the glass, leading to some rounding of the 
particles and some sintering. The scaffolds were still fragile. 
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Sintering at 700°C 
Scaffolds sintered at 700 °C were mechanically stable and could withstand manual handling.
 
Figure 4.4: SEM micrographs of SBP-1 scaffold sintered at 700°C at magnification a) 50,  b)1000x 
Pores were in the range 100-500 µm with high interconnectivity (Figure 4.4a). Figure 4.4b 
shows that at 700 °C more efficient sintering of the particles occurred. Individual particles 
were no longer visible and no angular particles were observed. Flow has occurred, indicating 
that 700 °C was above the Tg of the glass. Figure 4.4b shows the possible presence of 
surface crystals, however it may simply be glass particles caused by sectioning the scaffold. 
Small amounts of crystallisation were detected by XRD (Figure 4.7). 
 
 
 
 
 
 
        76 
Sintering at 710°C 
 
Figure 4.5: SEM micrographs of SBP-1 scaffold sintered at 710°C at magnification a) 50x     b)1000x 
 
Figure 4.5 shows the pore network after sintering at 710 °C. Although interconnected 
macropores were present, they were smaller than the pores seen in scaffolds sintered at 
700 °C (Figure 4.4) with thicker struts. Figure 4.5b shows a well sintered surface where most 
of the glass particles have flowed together. The reduction in pore size could be due to the 
flow of the particles during sintering causing a densification of the structure. 
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Sintering at 720°C 
 
Figure 4.6: SEM micrographs of SBP-1 scaffold sintered at 720°C at magnification a) 50x     b)1000 
 
Figure 4.6 shows SEM images of a scaffold sintered at 720 °C for 1 h. The pores (Figure 4.6a) 
were smaller compared to those in scaffolds sintered at lower temperatures, although they 
still fell between the 100-500 µm range. Figure 4.6b shows that the particles had almost 
completely sintered, with only small pores that were between the particles present. This is 
due to the higher sintering temperature, causing further densification of the struts. 
 
The study confirmed that as the sintering temperature increased the degree of particle 
coalescence increased also. Individual glass particles were still clearly seen in the samples 
sintered at 680 °C while those sintered at 720 °C exhibited a relatively smooth surface 
where the particles have fused together.  
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Crystallisation of SBP-1 scaffolds  
 
Figure 4.7: XRD patterns of SPB-1 scaffolds at sintered and held at varying temperatures for 1 hour 
 
XRD patterns were taken from each of the scaffolds and collated in Figure 4.7. The double 
peaks at around 30 and 31° 2θ for potassium sulphate, seen by Wu et al47., in their ICIE16 
scaffolds, were not present in any of the SBP-1 patterns, even though all the spectra showed 
some signs of crystallisation. As expected, the degree of crystallinity increased with sintering 
temperature, although even at 720 °C it still remained quite small. A few possible phases 
were identified, the most likely of which was calcium magnesium phosphate (ref. 00-024-
0135); calcium silicate (ref. 00-024-0234); zinc phosphate (ref. 00-011-0027) and sodium 
calcium phosphate (ref. 00-023-0669). It should be stressed however that due to the 
extremely small peaks and large amorphous halo, the identity of the crystalline phases 
cannot be confirmed.  
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SBF testing 
SBF tests were conducted with Lovoni Rahman (MSc student) to determine the bioactivity of 
the glass compositions SBP-1 with Bioglass as a standard74.  Figure 4.8 shows dissolution 
profiles in SBF, from ICP analysis, for the eight elements found in the SBP-1.  
 
Since SBF mimics the human body's blood plasma, it does not contain any silicon or 
strontium ions. When SBP-1 was immersed in the fluid, the concentration of Si and Sr were 
seen to rapidly increase with time before remaining at a relatively constant level. The 
concentration of Si and Sr levelled out from after one week of immersion - Si levelled at 70 
µgml-1, while for Sr it was 180 µgml-1 . Ca remained constant throughout the 3 weeks for 
SBP-1 at 135 ppm, while for Bioglass a sharp increase was seen in the first 72 h before it 
levelled off at 190 ppm.  Both compositions displayed a gradual decrease in P, which 
suggests that phosphate deposited onto the glass surface to form a HCA layer. The P levels 
in the SBF containing Bioglass dropped to 0, indicating a large amount of HCA formed, whilst 
for SBP-1 the concentration remained at 10 ppm. It should be noted from Table 3.1 though 
that SBP-1 contains 4.5 mol% P2O5, whereas Bioglass contains 1.07 mol%, so the higher P 
content in SBF containing SBP-1 could be due to the higher P content of the glass. However 
the difference is not as large as the difference in ICP data. It is therefore more likely that the 
SBP-1 is less bioactive than 45S5 in SBF. The concentration of Na remained relatively 
constant throughout the 3 weeks for the Bioglass powder at 2700 ppm, but the Na from 
SBP-1 displayed a sharp decrease from its constant level of 3100 ppm to 2500 ppm between 
2 and 3 weeks. It should be noted however that the variance for week 3 was very large. 
Sodium chloride may have deposited on the glass. The concentration of Mg rose sharply for 
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SBP-1, due to the presence of Mg in the glass (7.5 mol%). Only a very small level of zinc ions 
were detected for SBP-1 in the first few hours. This is because the glass only contained 3 
mol% Zn and also because Zn is tightly bound into the glass network, as it is an intermediate 
oxide and can therefore act as a network former106. 
 
SBP-1 caused a small increase in K concentration before remaining relatively constant at 255 
µgml-1, compared to ICIE16, which released almost 350 ppm over 1 week under the same 
conditions47.  
 
SBP-1 underwent dissolution in SBF and was shown to be bioresorbable. The concentration 
of P in SBF containing Bioglass dropped rapidly after 3 days, after which it further dropped 
to 0 after 1 week, which implies that phosphate precipitated from the SBF to form calcium 
phosphate. ICIE16 was also previously seen to cause the P content of SBF to drop to 0 at 1 
week, albeit at a slower rate than Bioglass47. While SBP-1 also caused a sharp drop in P 
concentration after 3 days, its level after that remained relatively constant at 10 ppm, which 
suggests that the bioactivity of the SPB-1 is lower than that of Bioglass and ICIE16.  
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Figure 4.8: Dissolution profiles of 45S5 and SBP-1 in SBF as a function of immersion time: 
 a) Ca b) P  c) Si  d) Na  e) Sr  f) K  g) Zn  h) Mg  
a) b)
c) d)
a)
c) d)
e) f)
g) h)
) )
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FTIR and XRD were then undertaken on the samples after three weeks of immersion (Figure 
4.9). There was no evidence of FTIR bands relating to the P-O bending vibration of a calcium 
phosphate within the SBP-1 (Figure 4.9a) 74.  Figure 4.9b shows the XRD pattern of the SBP-1 
powders after three weeks of immersion in SBF. The SBP-1 trace displays an amorphous 
halo, which indicates no presence of any crystalline phases.  
 
 
Figure 4.9: (a) FTIR spectrum and (b) XRD pattern of glass powders after 3 weeks of immersion in SBF 
 
A possible reason for the lower bioactivity of SBP-1 could be that it has a higher network 
connectivity (NC in Table 3.1) of 2.31 compared to Bioglass (2.10) and ICIE16 (2.13). 
However the network connectivity of SBP-1 could be even higher due if the intermediate 
oxides, ZnO and MgO (not present in ICIE16), act as network formers rather than network 
modifiers. If this was true, the network connectivity would be higher than that calculated as 
NC in Table 3.1, increasing to 3.01 (NC’). A glass with a network connectivity higher than 2.6 
is not expected to be bioactive48. The low amount of Zn dissolution detected suggests it may 
be acting as a network former. The magnesium release is substantial and literature suggests 
it can be a network modifier and former in the same glass. The actual network connectivity 
could therefore be between 2.31 and 3.01. 
a) b)
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Lower dissolution rates of SBP-1 compared to ICIE16 and ICIE16M could also explain why 
SBP-1 does not form potassium sulphate in the gel-cast foaming process, as a lower 
dissolution rate would further reduce the amount of potassium available. The reduction in 
bioactivity could be due to the zinc increasing the connectivity more than expected. For this 
reason, a new composition was designed that replaced the zinc with more strontium and 
calcium (SBP-3, Table 3.1).  
 
The phosphorus content of the glass was higher in SBP-1 compared to ICIE16, increasing 
from 1.07 mol% in ICIE16 to 4.5 mol% in SBP-1. This increase would increase HCA formation 
if the NC was the same, but the HCA formation rate was lower for SBP-1. This supports the 
theory that zinc (or magnesium) were behaving as intermediates in SBP-1. The increase in P 
can also increase the tendency for the glass to crystallise during sintering107.  
 
Summary: 
Amorphous scaffolds were successfully made from the melt-derived glass composition SBP-
1 without the formation of surface sodium potassium sulphate crystals using the gel-cast 
foaming process. The scaffolds did not exhibit bulk crystallisation despite an increased 
amount of phosphorus content in the composition compared to ICIE16. The optimal 
sintering temperature of composition was determined to be 720° with the scaffolds held in 
the furnace for 1h. SBF testing revealed that the dissolution profile of the SBP-1 composition 
was lower than that of Bioglass and ICIE16, which was attributed to the zinc taking the role 
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of network former and increasing the network connectivity of the glass, reducing its 
reactivity.  
 
4.2 In vitro cell culture 
An early stage in technology transfer is to assess the biocompatibility of the glass 
compositions. SPB-1 and SBP-3 were compared. To determine whether strontium affected 
the biocompatibility of a bioactive glass52, a modified composition of SBP-1 was made that 
did not contain any strontium substitution. The 16.3 mol% of strontium was replaced by 
calcium, taking it from 16.3 mol% to 32.6 mol%. This composition was termed SBP-2 (Table 
3.1). Further, zinc may have a detrimental effect on the growth of osteoblastic cells above a 
certain concentration58. Glass powder and scaffolds for the three compositions were made 
and provided to Dr Helene Autefage to conduct the cell culture testing. The cells used were 
human bone marrow derived mesenchymal stem cells (hMSCs) and human adipose derived 
stem cells (hASCs). Cells were seeded on the scaffolds, while an extract was made from the 
glass powders by adding them to the culture medium before it was filtered after 4 h. Cells 
were then added onto a 24 well plate and incubated at 37°C, with the time points for 
assessment at 1, 4, 7 and 14 days.  
Due to time constraints for the in vitro cell study of the SBP series, tests to optimise the 
sintering regime could not be undertaken, and so the scaffolds were sintered using the 
same protocol as that for SBP-1 (sintered for 1 h at 700 °C), meaning that the SBP-2 and 
SBP-3 scaffolds were fragile.  
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To determine the activity (viability) of cells in the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay was carried out using the dissolution products of the 
glass powders (extracts) and by seeding cells on the scaffolds. For the extracts, the 
metabolic activity significantly increased after 7 days of treatment of the cells for all three 
glass compositions. The level was sustained after 14 days for SBP-2 and SBP-3 but decreased 
for the SBP-1 extract.  
 
Results from the cells seeded onto the scaffolds were different compared to that of the 
glass extracts. In this case, the number of viable cells in all three glasses decreased with time. 
The most significant decrease was observed for the glass composition containing both zinc 
and strontium, SBP-1. The lowest decrease was found on the SBP-3 composition that 
contained strontium but not zinc, which maintained roughly the same level of cell activity 
throughout the 2 weeks.  
 
A possible explanation for the much lower amount of viable cells in the scaffolds than the 
extracts is that within the confined space inside the pores varied between samples causing 
the local environment for ionic concentration and pH to also change. Although zinc is a very 
likely candidate in contributing to the lower cell viability observed, it cannot fully explain the 
phenomenon since SBP-2, which contains zinc but not strontium, seems to be 
biocompatible. Another reason could be due to a detrimental effect on the cells caused by a 
specific concentration of ions released, or a batch effect since the scaffolds were only made 
from one batch.  
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The composition that exhibited the highest level of biocompatibility was SBP-3, followed by 
SBP-2. SBP-1, which contains both zinc and strontium, performed the worst out of the three 
glass compositions. Although taking out the zinc led to a higher cell compatibility, what was 
strange about these results was that SBP-2 contained zinc as well but not strontium, which 
was shown to be beneficial in studies52. 
 
Regardless, the results from the glass extracts were promising since all three glasses 
exhibited biocompatibilty, though further testing involving scaffolds from differing batches 
has to be conducted to verify these results. SBP-3 would therefore be used in further studies. 
 
  
4.3 SBP-3 
Results from the in vitro cell study were unfavourable for SBP-1, and suggested that its zinc 
content was detrimental to cells. Reports in the literature also showed concern over the 
toxicity of zinc108, so it was thought to be prudent to remove it from the composition. The 
SBP-3 composition was designed from taking the SBP-1 composition and replacing the zinc 
with strontium and calcium, with the hypothesis that the network connectivity of SBP-3 
would be similar to the NC value calculated in Table 3.1. The next step was to optimise the 
gel cast foaming process for the new SBP-3 composition, starting with the protocol used for 
SBP-1. The scaffolds were then once again tested to achieve the most efficient sintering. To 
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determine the porosity of a scaffold, the density of the glass composition had to be 
obtained first, which was done via helium pycnometry, Archimede’s principle and 
theoretical values obtained from mathematical models. The scaffolds were favourable, and 
they were up-scaled in collaboration with Ceram Research in order to produce enough 
samples for an in vivo study to determine their effectiveness. 
 
It was noticed from initial attempts at foaming SBP-3 that the level of the foam body during 
the gel-cast foaming process was lower than SBP-1 and SBP-2 (~80 ml compared to ~100 ml). 
Due to this, the resulting porosity and pore size was drastically reduced compared to the 
other two compositions. To address this issue, the effect of the amount of the surfactant 
Triton X-100 on foam volume and pore structure was investigated. Doubling the amount of 
surfactant used to 0.2 ml was found to produce a foam body of ~100 ml. With the amount of 
foam volume achieved the same as it was for SBP-1, the effect of sintering temperature was 
then investigated. Figure 4.10 shows a DSC trace for SBP-3 with a Tg onset of 614 °C and Tc  
onset of 785 °C, giving a theoretical sintering window of 174 °C. However, the water in the 
process was likely to lower the Tc onset. Therefore the sintering regime had to be re-
optimised. 
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Figure 4.10 DSC trace of SBP-3 particles run at 10 C/min showing a sintering window of 174 C (courtesy of 
Professor Robert Hill, QMUL) 
 
4.3.1 Sintering SBP-3 
Sintering temperatures were investigated between 680°C to 740 °C. Foams sintered at 
680 °C for 1 h were much too fragile, crumbling under the slightest of handling which 
showed incomplete sintering. Samples sintered at 700 °C could be handled, even if small 
parts crumbled from it. The samples sintered at 720 and 740 °C were mechanically 
competent, able to withstand handling with ease. Scaffolds sintered at 740 °C were stronger 
than those sintered at 720 °C.  
 
XRD patterns from the SBP-3 scaffolds (Figure 4.11) showed significant crystallisation 
occurred when the scaffolds were sintered at 720 °C or above. Just as with SBP-1, no trace 
of the phase potassium sulphate was seen even though the zinc was not present. It seems 
that the formation of these surface sulphate crystals can be inhibited by lowering the Na2O 
        89 
and K2O content to 4 mol%. Strangely, the scaffolds sintered at 680 °C seemed to be slightly 
more crystalline than the ones at 700 °C, although their degree of crystallinity were still  
extremely low. Attempts were made to identify the phases formed in the scaffolds sintered 
at 740°C, one of which appeared to be strontium silicate (ref. 01-076-1494) with its 
characteristic peaks at 27 and 32° 2Ɵ. One method to further distinguish the peaks would 
be to fully crystallise the sample by heating it well above its Tc. However, so many peaks 
formed that it was impossible to determine any specific phases. The sheer number of peaks 
produced was due to the high number of different phases formed, since the sample was a 
complex glass system composed of seven separate components. 
 
 
Figure 4.11: XRD traces of SBP-3 scaffolds held for 1 hour at varying temperatures. The marked peaks at 27 
and 32° 2θ indicate a possible phase of strontium silicate (ref. 01-076-1494) 
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Therefore sintering at 720 °C for 1 h produced scaffolds that could be handled, but the 
scaffolds had some crystallisation, whereas sintering at 700 °C for 1 h produced scaffolds 
with very little crystallisation but when handled, small amounts of glass would be lost from 
the scaffold due to incomplete sintering. Another way to improve sintering is to increase the 
hold time. Therefore the holding time at the sintering temperature of 700 °C was changed 
to determine whether complete sintering could be achieved without crystallising the glass. 
Samples were held at 1, 3 and 5 h at 700 °C and were then analysed by XRD. Figure 4.12 
shows that the degree of crystallisation did not increase significantly with holding time. The 
samples held for 3 hours were mechanically stable, with those held for 5 hours being even 
more stable.  
 
 
Figure 4.12: XRD traces of SBP-3 scaffolds sintered at 700°C with varied holding times 
 
A 3 h hold time was chosen so as not to risk crystallisation occurring and the optimal 
sintering regime was determined to be 690 °C and held for 3 hours. 690°C was chosen 
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because the threshold temperature seemed to be 700°C, above this the degree of 
crystallinity rose dramatically. Samples were made using this approach and the XRD trace of 
it can be seen in Figure 4.13, which does not display any significant crystallisation and yet is 
easily handled without breakage.  
 
 
Figure 4.13: XRD trace of SBP-3 scaffold sintered at 690°C for 3 hours 
 
4.3.2 Pore network characterisation of SBP-3 
To determine the pore size and interconnectivity of the SBP-3 scaffolds, µCT was performed. 
Figure 4.14a displays a 3D reconstruction of a scaffold, displaying high porosity and pore size 
homogeneity.  
 
In order to qualitatively see the pore morphology and connectivity of the scaffold, 3D image 
analysis was performed on the µCT image. A dilation algorithm was applied to binarised 
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images to find the centroids of the pores and obtain distance maps from the edge of pores 
to the centroids. A watershed algorithm performed on the distance maps identified the 
individual pores (Figure 4.14b). A top down algorithm combined with principle component 
analysis109 was used to identify the interconnects between the pores (Figure 4.14c) and 
obtain pore and interconnect size distributions (Figure 4.14d). 
 
 
Figure 4.14: Reconstructed µ-CT images of a SBP-3 scaffold and graph of its associated interconnect and pore 
sizes, courtesy of Dr Sheng Yue and Professor Peter Lee, University of Manchester a) µ-CT image of a SBP-3 
scaffold; b) µ-CT image of a SBP-3 scaffold’s pores; c) µ-CT image of a SBP-3 scaffold’s interconnects;  d) 
Graph of pore and interconnect size distribution of a SBP-3 scaffold 
a) b)
c) d)
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The pore size distributions (Figure 4.14d) showed pores ranging from around 90 µm to 700 
µm and a modal pore size of around 430 µm, while the modal interconnect size was 200 µm, 
exceeding the desired minimum of 100 µm for vascularised bone ingrowth. The total 
number of pores within the sample was 394, and the total interconnect number was 999. 
This means that on average, there were just under three interconnects to each pore, 
indicating the scaffold's high interconnectivity. 
 
Summary: 
Scaffolds were successfully made using the bioactive glass composition SBP-3, which was 
shown to possess high porosity and interconnectivity with pore and interconnect size within 
the desired range for optimal bone ingrowth. An optimal sintering regime was determined 
to be 690 °C held in the furnace for 3 h and no significant crystallisation of the glass 
occurred as well as an absence of sodium potassium sulphate crystals. 
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4.4 Confirmation of glass compositions 
To ensure the glasses produced had the expected amount of each element, samples of the 
SBP-3 glass powder were sent to Ceram Research (Stoke-on-Trent) for independent analysis. 
Scaffolds were also sent to determine whether sintering affected the elemental composition. 
The scaffolds were crushed into a powder such that they can pass through a 100 µm sieve 
prior to sample preparation. 
 
To prepare the samples for analysis, the powders were first dried at 110 °C for 4 h before 2 g 
was taken to be ignited at 500 °C. 1.5 g of the ignited material was then mixed with 7.5 g of 
lithium borate flux before fusing at 1025 °C in a platinum crucible. The fused sample was 
cast into a mould at 1200 °C and allowed to cool before analysis. 
 
 The elements tested for were Si, Ti, Al, Fe, Ca, Mg, K, Na, P, Cr, Mn, Zr, Hf, Pb, Zn, Ba, Sr, Sn, 
and S.  The sensitivity of the instrument was 0.01 to 0.02 %. Since the output of the 
instrument was in wt %, the data had to be converted into mol % of the corresponding oxide 
before comparisons can be made (Figure 4.21).  
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Figure 4.15: Bar chart comparing the glass powder composition and the crushed scaffold composition to the 
theoretical amount for SBP-3 
Table 4.1 shows that the difference between the theoretical mol % values of SBP-3 and the 
practical values achieved with the glass powder and the scaffolds are very similar. The 
values from the powder and the scaffolds are nearly identical, indicating the gel-cast 
foaming technique did not change the elemental composition.   
  
SiO2               Na2O CaO SrO K2O            MgO P2O5        
Theoretical
Scaffolds
M
o
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Table 4-1: Mol % of each oxide from the theoretical composition and the composition obtained from the 
glass powder and scaffolds from XRF. A percentage difference between the values is also given  
      SiO2 Na2O CaO SrO K2O MgO P2O5 
  
Theoretical 
mol % 44.50 4.00 17.80 17.80 4.00 7.50 4.50 
Glass 
powder XRF mol % 44.74 3.96 18.02 17.53 4.08 7.22 4.45 
 
 
Difference 
from 
theoretical (%) 0.53 1.00 1.22 1.50 1.92 3.71 1.02 
 
  
              
Scaffold XRF mol % 44.76 3.97 18.01 17.49 4.09 7.23 4.45 
  
 
Difference 
from 
theoretical (%) 0.58 0.75 1.19 1.72 2.18 3.58 1.13 
 
Table 4.1 displays the mol % of each oxide in the theoretical composition and that obtained 
through XRF on the glass powder and the scaffolds. The percentage difference between the 
theoretical and the practical values were very small: silica was out by 0.53 % in the glass 
powder and potassium was out by 2.18 % in the scaffolds. The results indicate that the glass 
that was produced via the melt-quench method for this study had acceptable accuracy. 
Magnesium oxide had a slight increased deviation from other oxides. This was possibly 
caused by the oxide possessing a higher volatility at elevated temperatures under reducing 
conditions110.    
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4.5 Density of SBP-3 
The SBP-3 composition produced promising scaffolds, but to quantify the porosity of the 
scaffolds produced, the skeletal density of the glass must first be determined. The porosity 
is determined via the following equation: 
    
     
         
 
(4.1) 
Where рbulk is the bulk density of the scaffold (scaffold mass/scaffold volume) and рskeletal is 
the skeletal density of the glass composition. The skeletal density can be calculated from the 
glass composition or experimentally by Archimedes principle. 
 
4.5.1 Skeletal density studies: Helium pycnometry and Archimedes’ 
Principle 
Helium pycnometry was performed on a sample of SBP-3 glass cast into a dense rod (Section 
3.5.6). The skeletal density of the sample was given to be 3.16 gcm-3. In comparison, 
Bioglass 45S5 has a skeletal density of 2.70 gcm-3 111.  
 
Two more rod samples were made and placed into an Archimedes rig. By measuring the 
weight of the samples in air and when immersed in water, and applying them to equation 
4.2, it is then possible to calculate the density of the samples: 
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(4.2) 
Where wa is the weight of the sample in air and ww is the weight of the sample when 
immersed in water.  
 
Three runs were performed for each of the two samples and an average density of 3.07  
gcm-3 was observed.  
 
4.5.2 Theoretical density values: Oxide density model and Doweidar’s 
model 
These values can be verified using theoretical models. A simplistic model was used by 
multiplying the weight fraction of each oxide in the composition by their respective oxide 
density, before summation. Using this approach gave a value of 3.25 gcm-3 for the glass 
composition SBP-3, similar to the values obtained experimentally. This approach however 
assumed that the oxides did not change structurally once incorporated into the glass 
network compared to their normal oxide state, which does not hold true.  
 
Another method used to calculate the theoretical skeletal density of SBP-3 was Doweidar’s 
model.  Doweidar identified that as the alkali ion content (RO and R2O) of a glass 
composition increased, the number of non-bridging oxygens to each silica tetrahedron 
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increased112. As the alkali content of a glass increases, the Q4 units progressively convert 
into lower numbered Q units. These Q3 and Q2 units, with the silica tetrahedra ionically 
bonded to the R species, change in volume only to the alkali species present and do not 
change in response to their concentration. The mass of each of these units can be calculated. 
A Q2 unit charged balanced by two sodium ions for example would have a mass equal to 
that of 1 silicon atom, 2 sodium atoms, 2 oxygen atoms and 2 half oxygen atoms (since two 
of the oxygens are bridging oxygens and so are shared by two silicons through covalent 
bonds). These atomic masses were totalled and multiplied by Avogadro’s number to obtain 
the mass of the Q2Na unit, as shown in equation 4.3. 
 
                                       
  
(4.3) 
Where ma is the atomic mass of each atom and NA is Avogadro’s number. 
With these values, it was then possible to obtain the density of each Q species within the 
composition, and thus the contribution to overall density that each unit gave. 
 
Doweidar then proceeded to develop the model to include other oxides, such as K2O and 
SrO2. NMR studies showed that P2O5 did not enter the network
30 and so for bioactive glass 
compositions the system’s network formers were split into a silicate glass phase and a 
phosphate phase 113. The densities of each of these phases are calculated separately before 
summation according to their weight fraction. It was found that the phosphate phase did 
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not preferentially take up Na+ and Ca2+ from the silicate phase113, and so the modifier 
content is split evenly by weight fraction between the two phases.  
 
4.5.3 Calculation of SBP-3 skeletal density via Doweidar’s model 
To calculate the skeletal density of the SBP-3 composition, it was first split into separate 
phases - the silicate glass phase and the phosphate phases. The phosphate phases formed 
would be Ca3(PO4)2 and Na3PO4, but since there were only 4 mol% of sodium oxide in the 
composition, only 2% would charge balance the phosphate phase. Once this phase’s density 
contribution was further reduced by its weight fraction, its impact on the overall density 
value would be negligible. Thus, this model assumes that only calcium is used to charge 
balance phosphorus in the phosphate phase of the glass.  
 
To separate the composition into the two phases, the phosphate content was first set aside. 
Since the assumption was that only calcium would charge balance it, 3 mol% of CaO was 
taken from the composition for each 1 mol% of P2O5 due to stoichiometry. The silicate 
phase was then normalised to 100 mol% and its network connectivity calculated as normal 
from that. From this, the fractions of Q2 and Q3 units within this phase could then be derived. 
The mass for each modifier within the glass was then calculated in proportions of Q2 and Q3 
unit (Q2Na, Q
3
Na, Q
2
Ca, Q
3
Ca...) and divided by their unit cell's volume, to give the cell density 
for each of them. This was then summed to give the overall density for the silicate phase of 
SBP-3, which was 3.06 gcm-3. The same method is applied to the calcium phosphate phase. 
The weight fraction of each of the two phases was then calculated (0.84 for the silicate 
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phase, 0.16 for the phosphate phase) and multiplied by each phase's respective cell density 
to give the overall true density of the glass system, which was 3.09 gcm-3. It should be noted 
however that two assumptions had to be made to arrive at this value: 
i) MgO had to be assumed to be a modifier completely, despite it being an 
intermeidate oxide that is known to a proportion acting as a former. 
ii) Doweidar did not give the unit cell volumes for Q2Mg and Q
3
Mg in his papers, and so 
these two values had to be assumed. After consultation with Prof. Robert Hill 
(QMUL), it was decided that a close estimate for Q3Mg was 50 10
-24 cm3 and Q2Mg was 
60 10-24 cm3. 
Despite these assumptions, the obtained value supported the values given by the other 
methods.  
 
Of the various methods to determine the true density of a glass, the Archimedes method 
was the simplest to implement and thus the most reliable. The value for true density 
measured by Archimedes method for SBP-3 was 3.07 gcm-3, which agrees with the 
theoretical value from Doweidar’s model, therefore 3.07 gcm-3 was used in further 
calculations. 
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4.6 Up-scaling the gel-cast foaming process 
While samples were made that were suitable for bone regeneration purposes using the gel-
cast foaming method, the quantities obtained in the laboratory would not be sufficient for 
commercial purposes.  As part of a project that had the aim of progressing the technology 
transfer of the bioactive glass scaffolds, a study in collaboration with Ceram Research 
(Stoke-on-Trent, UK) was performed with an aim to up-scale the gel cast foaming process 
for the SBP-3 composition, switching from making batches in a 250 ml container to a multi-
litre container. 
 
To determine whether the lab conditions at the Ceram laboratory were similar to that on 
campus, batches of SBP-3 were made at the standard concentrations without any up-scaling 
factor.  It was found that the batches experienced a retarded gelation time, likely due to 
different atmospheric conditions. The samples that were foamed to the standard 90 
seconds did not set sharply as normal and instead underwent a slow gradual gelation that 
led to collapse of the structure after approximately 130 seconds. Hence, foaming time was 
increased until an adequate foaming time was found at 2 minutes, with the gelation time 
following around 15 seconds after.  
 
For the initial up-scaling attempt, a 2 litre high shear columnar mixer with variable speed 
setting was used (Figure 4.15). It was noted that above a mixing speed of 500 rpm, the 
gelation behaviour of the slurry changed drastically from the norm in that no gelation 
occurred even after an extended period of time. It was speculated that the mixer imparted 
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too much shear energy into the system. It was possible that polymerisation was inhibited by 
the shear. However, even when the agitation was stopped gelation still did not occur, 
implying that the free radicals had been used up, so an alternative possibility is that polymer 
chains started to form but were broken again as a result of the high energy mixing. This 
phenomenon did not occur when the speed of 300 or 400 rpm was selected, though the 
gelled green bodies seemed highly dense and did not exhibit any observable porosity. The 
process of foaming between the high shear mixer and the hand whisk were different in that 
the mixing blades of the hand mixer introduced air by ‘folding’ the slurry, while the high 
shear mixer drew in slurry through apertures in the top of the stator (Figure 4.15a), where 
they passed through the mixing blades before being released through the base of the stator. 
Some of the samples were cut into 1.5 cm3 cubes and sintered. After sintering, it was noted 
that all of the samples contained black cores due to carbon residue (Figure 4.15b). This was 
due to the lack of interconnectivity within the samples and so during the polymer burn-out 
period the carbon had nowhere to escape from the system. Due to this highly energetic 
mixing process that led to scaffold collapse, the columnar mixer was not an adequate device 
to up-scale the gel-cast foaming process.  
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Figure 4.16: a) A high sheer mixer in which slurry is drawn in through the holes in the columnar rotor and 
mixed at high speed before exiting once again. b) Sintered samples produced via high sheer mixing, 
displaying black cores and a lack of porosity leading to stress cracking.  
 
A Hobart N50 mixer was used next to determine its effectiveness. The container had a 
volume of 4.6 L and so could contain a larger batch. Here, up-scaling factor is defined as the 
number by which the reagent quantities were multiplied. An up-scaling factor of 25 was 
applied to ensure an adequate level of slurry in the mixing bowl. The mixer had 3 speed 
settings, and the fastest setting was used first. Two minutes of agitation was used as a 
standardised foaming time in scale-up testing. This gave rise to a green body that was 
similar to those obtained via the high shear mixer: it had no observable pores and was a 
dense block, and so it was deduced that the speed was too high. Trials with the two lower 
settings however did not give rise to satisfactory samples. The batches would either gel 
during the foaming stage, leading to ruined samples, or did not foam sufficiently to give 
interconnected pores (Figure 4.16).  
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Figure 4.17: a) A collapsed green body from a trial using the Hobart mixer. Note the low porosity of the 
sample and the heterogenous pore size distribution.  
 
 The foaming method contributes greatly to the success rate of a scaffold. The mixing 
process of the Hobart N50 mixer utilised a multi-wire whisk to foam the slurry, in contrast to 
the mixing blades of the hand held Kenwood hand mixer (Figure 4.17). The type of blade 
may affect the efficiency of air incorporation. 
 
 
Figure 4.18: Profile and cross-section diagrams of the mixing heads between a) the Hobart N50 mixer and b) 
Kenwood Chef hand mixer. 
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With this in mind, it was decided that the foaming method should remain the same, but the 
container size was increased. A 1 L mixing container and an up-scaling factor of 5 was used. 
To ensure proper mixing of the increased volume of slurry two mixing blades were used. The 
foaming and gelation characteristics of these samples were the same as that of the lab-scale 
batches performed at Ceram at the beginning of the up-scaling trial, and the green bodies 
did not collapse (Figure 4.18). 
 
 
Figure 4.19: A green body produced via the up-scaled Kenwood Chef method. Note the higher porosity 
compared to Figure 4.15 and the much more homogenous distribution of pore sizes. 
 
It was noted that the ratio between dimensions of the two processes were similar (Figure 
4.19), and combined with the same foaming method used, may have explained the relative 
ease in which the gel-cast foaming process was up-scaled. This method did not affect 
gelation time compared to the lab-scale batches performed at the beginning of the up-
scaling trial.  
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Figure 4.20: Diagrams of the distance between the mixing blade and the circumference of the mixing 
container (d1) and the radius of the container (d2) in a) the standard foaming method and b) the x5 up-
scaled foaming method. The ratio of d1/d2 between the two methods are similar. 
 
A problem emerged with the up-scaling process however in that during the cooling period 
after polymerisation, cracks started to form on the surface. The heat was generated by the 
in situ polymerisation. The cracking was due to cooling gradient between the surface and 
the core of the green body. The surface was cooling faster than the bulk of the sample such 
that stresses formed. While lab-scale samples still have to cool, the stresses induced were 
not sufficient to cause any cracking. This problem was resolved by reducing the rate of 
cooling at the surface by appliance of a PVC film over the top of the mixing container. This 
film was kept until the sample had cooled to room temperature, before the usual steps of 
cutting and sintering occurred.  
 
The scaffolds produced were ground using a cone mill to give granules of sizes 1-3 mm 
(similar to Actifuse). The pore size distribution (effectively the interconnect size distribution) 
measured by mercury porosimetry is shown in Figure 4.20. The modal interconnect size was 
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65 µm. This was lower than the ideal 100 µm, but was as large as the up-scaled process 
could produce. The modal interconnect size was also lower than that produced by the lab-
scale process (Figure 4.13). Image analysis of the lab-scale scaffolds found the modal 
interconnect size to be 200 µm. However, the micro-CT analysis tends to overestimate the 
size (due to the 7 µm voxel size) and mercury porosimetry can underestimate the size 
because the technique assumes the pores are cylindrical. Figure 4.20 shows there are many 
interconnects larger than 65 µm. 
 
Figure 4.21: Mercury intrusion porosimetry graph of an up-scaled scaffold produced via the up-scaled 
process 
 
4.6.1 Up-scaling trial conclusions 
Up-scaled batches of SBP-3 were successfully produced during the trials with a scaling factor 
of 5. However the largest modal interconnect size was smaller than what was achieved 
using the laboratory scale method.  It was found that the foaming technique greatly 
affected the resulting structure of the green body, and so use of the hand mixer (Kenwood) 
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was retained to a larger mixing container with a volume of 1 litre, albeit foaming was 
performed with two blades rather than one. The ratios of the dimensions in the up-scaled 
apparatus were similar to the standard one in terms of height to circumference, as well as 
the ratio of the distance between the blade to the circumference and the diameter of the 
mixing container. While this reduced the up-scaling potential compared to that offered by 
the high shear mixer (volume ~2 L) or the Hobart N50 mixer (volume 4.6 L), attempts to up-
scale production using those techniques were unsuccessful.  
 
4.7 In-vivo data of up-scaled scaffolds 
Scaffolds from the up-scaled process were provided to Professor Allen Goodship and 
Gordon Blunn (University College London, UCL) for a three month in vivo ovine study using 
the femoral condyle. Their team performed the operations and the following bone mineral 
analysis.  
In vivo procedure 
Crushed samples of porous SBP-3 (granules 3 - 5 mm) were compared with dense Bioglass 
particles (0.1-1 mm).  The animals did not show post-operative adverse effects to the 
implants, though there was slight subcutaneous fibrosis caused by the resorbable Vicryl® 
sutures. The number of required sheep for each treatment group was determined to be six. 
The study was carried out under project and personal licences granted by the Home Office 
under the Animals (Scientific Procedures) Act 1986. Thirty-six female sheep, at least two 
years old and in good health, were selected and randomly allocated to a treatment group. 
Three recently sacrificed sheep of the same criteria were used prepare time zero samples 
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with the surplus test materials. An 8 mm diameter cylindrical defect was made to a depth of 
15mm in the left medial femoral condyle. The bone graft material was prepared a ratio 2:1 
of ovine blood to graft and allowed to coagulate. The graft was pressed into the defect and 
compacted using a spatula. Kirschner wires were inserted adjacent to the defect for 
radiographic identification. The sheep were sacrificed at 42 or 91 days after implantation 
and the left medial condyles were retrieved using an oscillating saw. 
 
Radiology 
Quantitative Computed Tomography (QCT) of the femoral condyles was used to measure 
the amount of bone mineralisation and to qualitatively see the amount of bone remodelling. 
QCT is similar to X-ray tomography, except that a calibration standard was used to convert 
the output into bone mineral density values. Multiple scans across the defect were taken 
and used to find the approximate centre of the defect. A region of interest encompassing 
the defect was then used to calculate the defect bone mineral density (BMD). BMD was also 
measured proximal and distal to the defect. After scanning, the defect was sectioned in the 
frontal plane using an Exakt diamond-edged bandsaw. 
 
Histological analysis 
Sections of (95–100 µm) were stained for light microscopy with Toluidine Blue for thirty 
minutes to stain soft tissue and Paragon for twenty minutes to stain bone. A cover slip was 
then applied to the surface of each slide. The percentage of bony ingrowth was measured 
using a Weibel grid composed of 225 points (Weibel & Elias 1976). Percentage bone 
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ingrowth was calculated by measuring total area occupied by bone relative to the total 
defect area. The bone coverage on the implant surfaces was measured from one aspect of 
the section and calculated as the percentage of particle surface occupied by bone ingrowth.  
 
In vivo results 
Figure 4.22 shows a 2D X-ray image of the scaffold immediately after implantation. Pore 
diameters seem to be in the range 200-400 µm, however this is from a 2D slice, so pores are 
likely to have a mean pore size close to 400 µm in 3D. 
 
Figure 4.22 X-ray slice of the SBP-3 granules in the defect at time of implantation (t=0). Courtesy of Gordon 
Blunn (UCL) 
Figure 4.23 shows histology slices of Bioglass at 42 days (Figure 4.23a) and SBP-3 at 42 days 
(Figure 4.23b) and 91 days (Figure 4.23c). The SBP-3 scaffold stained dark red and new bone 
stained pink. The white areas seen in Figure 4.23a are the Bioglass particles. The light areas 
in Figure 4.23b and Figure 4.23c are the pores filled with marrow and fat cells. Both samples 
1 mm
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show bone ingrowth (B) occurred in the defect. The architecture seen in the SBP-3 sections 
however showed a greater resemblance to trabecular bone at both time points. New bone 
was seen inside the pores of the SBP-3 scaffold at 42 days (Figure 4.23b). The bone grew 
along the internal walls of the pores. Figure 4.23c shows how interconnectivity of the pores 
is important for bone ingrowth. However in some pores, the new bone does seem to block 
the interconnects. If the new bone does not contain blood vessels, then the new bone may 
be cut off from nutrients and die. Blood vessels were not stained, so it is difficult to assess if 
they are present. The sealing off of some interconnects may not be a problem if remodelling 
of the scaffold occurs. If this blocking of the interconnects is found to be a problem in 
further studies, it could mean that the 3-D grid-like structures produced by 3-D printing 
techniques perform better than trabecular-like scaffolds. 
 
Comparison between Figure 4.23a and Figure 4.23b suggests that the amount of bone 
ingrowth is greater in the SBP-3 filled defects compared to those filled with Bioglass. This 
could be due to the dense packing of the Bioglass not allowing space for bone ingrowth. 
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Figure 4.23 Histology of slices from bone defects stained with Toludine Blue (soft tissue) and Paragon (bone): 
(a) Bioglass at 42 days; (b) SBP-3 at 42 days; (c) SBP-3 at 91 days. Scale bar is 200 µm. BG = bioactive glass; B 
= new bone; P = pore. Courtesy of Gordon Blunn (UCL) 
 
Figure 4.24 Backscattered SEM micrograph of SBP-3 following 91 days implantation in the ovine model. 
Courtesy of Gordon Blunn (UCL). Outline indicates size of original pore, the grey area inside it represents the 
amount of bone ingrowth into the pore.  
 
Figure 4.24 seems to suggest that the interconnects increased in size as implantation time 
increased (comparing with Figure 4.22), indicating degradation. There seemed to be little 
degradation of the Bioglass particles. This is surprising given that the SBP-3 composition has 
a higher network connectivity (2.4, Table 3.1) compared to 45S5 Bioglass (2.1). The Bioglass 
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degradation was likely to have been inhibited by its high degree of packing in the defect. 
SBP-3 allows more fluid flow into the defect and higher surface area exposure to fluid due 
the large size of granules and the porosity of the granules. To study the effect of the 
compositions, an ideal study would have been to use porous Bioglass granules, but since this 
cannot be achieved without significant crystallisation (Chapter 1), it would have reduced 
bioactivity. Comparison of SBP-3 particles to Bioglass particles would be of less interest due 
to the low rate of remodelling seen in the defects filled with the Bioglass particles. 
 
Porous bioactive glass scaffolds do not always give improved results in vivo compared to 
Bioglass. A recent study compared a sol-gel bioactive glass (70S30C, 70 mol% SiO2, 30 mol% 
CaO) to NovaBone particles (90-710 µm) and Actifuse (porous Si-HA) in a rat tibia model118. 
The Actifuse had a similar pore network to the sol-gel foam (interconnects of approximately 
100 µm) and performed well, with all the pores filled with new bone at 11 weeks. However 
no bone grew into the sol-gel foam. The sol-gel foam had a similar pore network to that of 
the SBP-3 scaffolds. The difference is that the sol-gel scaffolds degrade at a higher rate, 
releasing more calcium ions. The work showed that when the sol-gel foams were 
preconditioned (soaked in media for 24 h prior to implantation) they stimulate bone 
ingrowth as the Actifuse did, but they also degraded (the Actifuse did not show any 
degradation). The NovaBone particles stimulated bone ingrowth but as they were particles, 
some of the particles moved into the bone marrow cavity. 
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The alkali burst effect commonly exhibited by implanted scaffolds can be reduced through 
preconditioning before implantation or in vitro studies. Preconditioning involves soaking the 
scaffolds in media for a period of time first such that the rapid leaching of ions such as Na+ 
would not occur again once implanted or studied in vitro. It was postulated that in the 
unpreconditioned scaffolds, the pH build up inside the pores prevented bone ingrowth. 
Therefore the fact that the SBP-3 scaffolds have such high bone apposition but have a 
network connectivity that causes slow dissolution may be an advantage. Unfortunately it is 
not possible to produce porous 45S5 glass scaffolds (that remain amorphous) so we do not 
know if porous 45S5 scaffolds with a foam-like pore structure would encourage bone 
ingrowth or have a build up of pH inside the pores.  
 
 
4.7.1  In-vivo study conclusions 
The results from Professors Goodship and Blunn showed that SBP-3 not just displayed a 
higher amount of bone ingrowth to the dense Bioglass particles, but the bone formed also 
resembled a more natural architecture to trabecular bone. While this difference may have 
been caused by scaffold nature of the SBP-3 samples rather than the glass composition, it 
still shows that scaffolds have great potential. 
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5 Adapted Gel-Cast Foaming 
5.1  Introduction: need for a new process 
Due to the complex nature of the gel-cast foaming process, there are difficulties in up-
scaling the process for commercial purposes. For the method described in section 4.4, an 
up-scaling factor of five was achieved. This is in part due to the complexity of the gel-cast 
foaming process, with the large number of process variables and the relationship between 
them. Up-scaling could be improved by simplifying the process. 
 
Another issue with the original process was the formation the sodium potassium sulphate 
crystals on the glass surface. The crystals formed due to dissolution of the sodium and 
potassium from the glass in the wet gel-casting process, and the reaction of those ions with 
sulphate from the polymerisation initiator. While the SBP-3 composition eliminated crystal 
formation, by reduction of sodium and potassium ions in the glass, SBP-3 showed reduced 
bioactivity in SBF compared to other compositions such as ICIE16. In fact the reduction in 
the dissolution rate will also have contribution to the prevention of the sodium potassium 
sulphate crystals. In order to return to the ICIE16 composition, it would be necessary to: 
1.  Change the monomer-initiator system 
2. Change the gelation mechanism 
An alternative initiator that could be used in place of ammonium persulphate is 
azobisisobutyronitrile (AIBN), which does not contain any sulphur. It cannot however be 
used in the gel-cast foaming process as it is insoluble in water and therefore it cannot be 
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used with the surfactant foaming process. The surfactants will only work in the presence of 
water. 
 
Other monomer-initiator systems are available, ranging from methoxy poly(ethylene glycol) 
monomethacrylate with the initiator azobis [2-(2-imidazolin-2-yl) propane] HCl to a 
copolymer of n-vinyl pyrrollidone and methoxy poly(ethylene glycol) monomethacrylate 
again with the initiator being azobis [2-(2-imidazolin-2-yl) propane] HCl. These monomer-
initiator systems possess an equal, if not higher, gel strength to the methacrylamide-
ammonium persulphate system according to Janney et al. The problem however is that 
further information cannot be obtained regarding the initiator azobis [2-(2-imidazolin-2-yl) 
propane] HCl.   
 
The alternative is to simplify the process by omitting the initiator step. Gelatin, a protein 
derived from the partial hydrolysis of collagen, was used as a gelling agent in gel-casting by 
Vandeperre et al. to produce a dense ceramic sample114. A simple system consisting of the 
ceramic powder alumina, water, the dispersant Darvan C and gelatin was mixed and de-
aired to remove any pores formed before the usual steps of drying and sintering were 
undertaken. A low temperature (ice bath) was all that was needed to begin the gelation 
process.  
 
The main disadvantage in this method was the natural formation of a foam from the mixing, 
which was undesirable if the intent was to produce a dense ceramic. A de-airing step was 
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added to remove the inherent bubbles formed in the process. However this would not be a 
problem for scaffold production. So the aim here was to modify the gel cast foaming process 
by replacing the gelation method of free radical polymerisation with thermal gelation of 
gelatin. This chapter describes the process development and optimisation of the process 
through investigation of the process variables. The process was developed using the SBP-3 
composition for two reasons: i) the excellent in vivo results obtained from the SBP-3 glass 
foam made with the previous gel-cast foaming method; ii) to enable a direct comparison of 
the new process with the old on a single glass composition.  
 
5.2 Methods 
5.2.1 Glass synthesis 
The SBP-3 composition (44.5 mol % SiO2, 4.0 mol% Na2O, 17.8 mol% CaO, 17.8 mol% SrO, 
4.0 mol% K2O, 7.5 mol% MgO, 4.50 P2O5 (Section 3.1) was used. The glass was melted at 
1200 °C and quenched into water.  
5.2.2 Particle sizing 
For proof of principle of the new process, particles of SBP-3 were prepared by jet milling, as 
in section 3.3.1. Due to problems with contamination (Section 5.3.6), investigation of the 
process variables and subsequent optimisation of the modified process was done using 
particles that were ground on a gyro mill (section 3.3.2) and sieved through a 32 µm sieve 
with ultrasonic deblinder. Particle sizes were measured (section 3.5.4).  
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5.2.3 The modified gel-casting foaming process 
The initial process involved mixing the bioactive glass, water, gelatin and dispersant at 35°C. 
The higher temperature was needed to discourage premature gelatin gelation. The gelatin 
used in this study was Type A gelatin derived from porcine skin. Type A was chosen because 
Type B gelatin takes a long time to gel115. The slurry was foamed through vigorous agitation 
with the aid of a surfactant (Triton X-100) for two minutes to produce a foam structure. 
Initially 0.2 ml of Triton X-100 was used. The foaming vessel was then placed into an ice bath 
to initiate gelation and held for 6 minutes until an adequate gel strength was produced.  
 
Initial attempts to produce scaffolds using the thermally-stabilised gel-cast foaming method 
showed that the system was simple enough that a dispersant need not be used, thus 
reducing further the number of components from nine in the first method, to four: glass, 
water, gelatin and surfactant. This allows for simpler optimisation of the process, since 
there are fewer variables to account for.  
 
An oven can no longer be used to dry the samples since any increase in temperature will 
simply collapse the pore morphology as the gelatin once again dissolves. Freeze-drying is an 
alternative method to removing the water from the green body, such that the scaffold can 
later be sintered without collapsing. To facilitate this, the green body is placed into a freezer 
after gelation in an ice bath. After 15 minutes, it was taken out of the mixing containing and 
placed into a deep freezer set to -80°C for 2 hours to prepare it for freeze-drying. The 
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sample was then left in the freeze-dryer (Cool-Safe 110-4, -110°C, 4x10-4 mbar) for 2 days to 
remove all the water from the system. After this, the dried green body can easily be cut 
(Figure 5.1) and shaped to requirements before being placed into the furnace for gelatin 
burnout and sintering. Shrinkage was found to be in the region of 60-70%. 
 
 
Figure 5.1 Freeze dried  green bodies can be easily cut to shape 
 
After freeze-drying the scaffolds were thermally treated. Gelatin burns out at 400°C, so 
scaffolds were held at 500 °C for 1 h following a heating rate of 2 °C/ min to ensure 
complete burn out. The scaffolds were then sintered by raising the temperature at 2 °C/ min 
to the selected sintering temperature. 
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Figure 5.2: The adapted gel-cast foaming process 
Freeze drying consists of 3 steps: freezing, primary drying and secondary drying. The 
aqueous solution has to be brought below its triple point in order for sublimation to occur. 
This normally leaves 1-4% water in the sample and the process takes 3 days.  
 
Figure 5.2 shows the intended process of the gelatin gel-cast foaming method, the amount 
of each variables used to optimise the process are discussed below.  
 
There are several variables in the process that needed investigation. Initially proof of 
principle of the new process was needed. The initial aim was to determine whether foam 
scaffolds could be produced with efficient sintering and without slumping and without glass 
crystallisation using the new method. The first variables that were investigated were 
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i) Gelatin : water concentration 
ii) Glass loading 
iii) Sintering temperature 
Once the effect of these variables on sintering efficiency and crystallisation was known, 
further optimisation of the scaffolds was carried out through investigation of the following 
variables on sintering efficiency, crystallisation, mechanical properties, rate of HCA 
formation and dissolution rate in SBF: 
i) Sintering dwell time 
ii) Surfactant concentration 
 
5.3 Results 
5.3.1 Gelation mechanism 
Since the gelation system is no longer a free-radical polymerisation reaction, the drying and 
consolidation stage would be longer. Gelation for the old process was ~90s. When gelatin 
was used, the foaming was carried out for two minutes to create a stable foam and then the 
foam can be stabilised through cooling in the ice bath. The amount of time required for 
freeze-drying depended on sample size; the smaller the sample, the shorter the drying step 
became.  Time for freeze-drying was determined by freeze-drying a large sample from a 
batch and freeze-drying until there was no further weight loss. 
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5.3.2 Gelatin content 
The effect of gelatin concentration on the ability to produce a foam scaffold was 
investigated. Gelatin concentration was found to determine the gelation and stabilisation of 
the foam structure:  too much will cause the slurry to become too viscous to be foamed, 
while too little will mean that there will not be enough gelling agent to retain the porous 
structure, leading to collapse. Initially an equivalent amount of gelatin to the amount of 
monomer was used and cross-linked employed in the original gel-cast foaming process 
(Chapter 4), i.e. 10g of glass in 20 ml of water with 5g of gelatin foaming 0.2 ml of surfactant. 
However, the slurry was too viscous and could not be foamed, even if the surfactant 
concentration was increased. Therefore the gelatin content was reduced to 0.5 g, 1 g and 2 
g. At 0.5 g of gelatin, the gelatin concentration was insufficient to gel the slurry, resulting in 
collapse of the foam once agitation was stopped. Using 1 g of gelatin with 0.2 ml of 
surfactant produced a successful foam (foam volume of 100 ml from ~40 ml starting slurry). 
However when the amount of gelatin was increased to 2 g, the viscosity was too high, and a 
foam volume of only ~60-70 ml was achieved.  
 
Figure 5.3a and Figure 5.3b shows that foaming with 1 g of gelatin produced scaffolds with 
an open porous structure. Increasing the amount of gelatin to 2 g resulted in a reduction in 
pore size and interconnectivity (Figure 5.3c and Figure 5.3d). The pore network was also 
heterogeneous and pores partially collapsed in some areas, and as such the optimal gelatin 
concentration was found to be 1 g of gelatin in 20 ml of deionised water. 
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Figure 5.3: SBP-3 scaffolds with 1 g gelatin sintered at 690 °C for 3 h. a) at 50x magnification b) at 100x 
magnification. 2 g of gelatin was used for c) and d), at 50x and 100x magnification respectively. 
  
5.3.3 Sintering temperature 
Before investigating the effect of sintering temperature, the glass loading was increased 
from 10 g to 14 g. This was to reduce slumping of the scaffolds during sintering. Slumping 
occurs after burnout of the polymer (gelatin) binder (section 5.3.4). Starting with a glass 
concentration of 14 g with 1 g of gelatin in 20 ml of water the glass slurry was foamed with 
0.2 ml of surfactant. A foam volume of 140 ml was achieved. Scaffolds were sintered for 3h 
at 690 °C, 700 °C and 710 °C. Figure 5.4 shows that increasing the sintering temperature 
from 690 °C to 700 °C improved the sintering efficiency.  
Glass 10 g
Gelatin 1g
Sintering 
690°C
Glass 10g
Gelatin 2 g
Sintering 
690°C
a) b)
c) d)
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Figure 5.4: SBP-3 scaffolds sintered at varying temperatures. a), c) and e) are at 50x magnification and b), d), 
f) are at 100x magnification 
Figure 5.4a, Figure 5.4c and Figure 5.4e show that successful foams were produced with 
open pore networks. In Figure 5.4b some morphology of the glass particles can still be 
observed, whereas Figure 5.4d and Figure 5.4f show scaffolds with smooth struts. As 
sintering at 710 °C caused some crystallisation in scaffolds made with the previous method 
(Chapter 4), a sintering temperature of 700 °C for 3 h was taken as optimal. However, the 
handling properties of the scaffolds were poor. The scaffolds were brittle, losing small 
particles as they were handled (Figure 5.5). Further optimisation of the sintering was 
needed. Another issue was that these samples were still slumping during sintering.  
Glass 14 g
Gelatin 1g
Sintering
690 °C
Glass 14 g
Gelatin 1g
Sintering
700 °C
Glass 14g
Gelatin 1g
Sintering
710 °C
a) b)
c) d)
e) f)
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Figure 5.5: Samples of SBP-3 scaffolds sintered at 690°C for 3 h, made with 14 g of glass, 1 g gelatin and      
0.2 ml surfactant.  
 
5.3.4 Glass loading 
Before the sintering regime was optimised further in terms of sintering efficiency, the 
priority was to reduce slumping during sintering (Figure 5.6). Slumping occurs when the 
polymer binder (the gelatin in this case) is burned out if there is insufficient packing of the 
particles. The polymer is removed below the Tg of the glass and therefore before any 
sintering of the glass can occur. If the particles are poorly packed, the foam will collapse 
under the weight of the particles (Figure 5.6).  
 
 
Figure 5.6 Schematic of foam sintering and slumping 
Sintering or
Pore network slumped
Foam
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Once the polymer is removed, the particles are in contact with each other (Figure 5.7) and 
to prevent slumping, they must be packed such that they stabilise the foam. Sintering is also 
promoted by surface area and particle contact. Increasing glass loading increases particle 
packing. Reduction in particle size also improves packing, but the increase in surface area 
can induce crystallisation at lower temperatures, when crystallisation is surface nucleating. 
 
 
Figure 5.7 The sintering regime for SBP-3 with the adapted gel-cast foaming method. 
 
The effect of glass loading was investigated for loads of between 10-30 g in 20 ml of water. 
The surfactant amount used in each batch was kept constant 0.2 ml of Triton X-100.  
 
A suitable consistency during foaming was found for samples made at 25 g of glass, while 
SEM shows that the pore morphologies appear more suitable for bone ingrowth at 25 g 
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used. With the amount of glass confirmed, it was decided that in order to increase the 
sample’s ability to withstand handling, the holding time should be increase further to 5 h. 
Since increasing hold time induces crystallisation, the sintering temperature was reduced to 
690°C. Figure 5.8 shows an XRD trace of such a scaffold undergoing sintering at 690 °C for    
5 h. Again, there is no sign of significant bulk crystallisation and the sample responded well 
to handling.  
 
Figure 5.8: XRD trace of SBP-3 sample sintered at 690 °C for 5 h. 
 
5.3.5 Surfactant concentration 
With the optimal glass loading and sintering regime determined, the pore structure could 
then be investigated further. The variable most affecting the foam volume, and hence bulk 
density and porosity, was the surfactant concentration (Triton X-100). Starting from an 
amount of surfactant of 0.1 ml in each batch of glass slurry (25 g of glass in 20 ml of water), 
the amount of surfactant was increased and its effect on foam volume and pore morphology 
was investigated.  
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Figure 5.9 Effect of surfactant concentration on foam volume (in a batch of glass slurry of 25 g of glass in 20 
ml of water). 
Figure 5.9 shows that between surfactant amounts of 0.1 - 0.3 ml, the foam volume 
increased marginally. As the surfactant was increased from 0.3 to 0.4 ml, the foam volume 
increased to 130 ml. As the surfactant was increased further to 0.5 ml, the foam volume did 
not increase but started to stabilise. When 0.7 ml of surfactant was used, the slurry did not 
foam. This is due to the concentration being above the critical micelle formation limit, 
where the surfactant molecules form self-assembled spherical structures, with the 
hydrophilic heads of the surfactant molecule on the surface and the hydrophobic tails on 
the inside (Figure 5.10).  
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Figure 5.10: a) Schematic of a micelle- at excess concentrations of surfactant in a given solution, the 
surfactant molecules arrange themselves into a structure with the hydrophilic heads facing the aqueous 
environment, and the hydrophilic tails on the inside. b) Schematic of a surfactant working efficiently, 
stabilising an air bubble in water. Not to scale. 
 
With the surfactant no longer present in free form to reduce the surface energy of the slurry, 
foaming did not occur in sufficient quantities to create a stable porous network and thus 
leading to foam collapse.  
 
SEM was used to investigate the effect of surfactant concentration on pore network 
morphology (Figure 5.11). All scaffolds were sintered for 5 h at 690 °C.  
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Figure 5.11: x100 SEM images of  scaffolds foamed with varying  amounts of surfactant a) 0.1 ml b) 0.2 ml        
c) 0.3 ml d) 0.4 ml e) 0.5 ml f) 0.7 ml. Scale bar is 100µm. 
 
The SEM images indicate that all of the samples sintered well. The individual particles were 
no longer visible and the scaffolds had a smooth surface topography. The porosity of the 
pores increased as surfactant concentration increased from 0.1 to 0.4 ml (Figure 5.11). For 
the sample foamed with 0.7 ml of surfactant Triton X-100, the porosity decreased, probably 
due to the critical micelle concentration being exceeded. While pores still formed, the 
interconnectivity of the sample dropped dramatically; Figure 5.11f shows a heterogeneous 
pore network with many closed pores and very few interconnects. Figure 5.11a and 5.11b 
both exhibit a similar pore structure that, while open to an extent, possessed a low porosity 
with small pores and inadequate interconnect size for bone ingrowth and blood vessel 
infiltration.  
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The most promising scaffolds for bone regeneration indicated by Figure 5.11 were the ones 
foamed using 0.4 and 0.5 ml of surfactant Triton X-100 (Figure 5.11d and 5.11e). These 
samples possessed an extremely open pore structure and many interconnects can be seen 
between the pores. From the images, the pore diameter appeared to be in the range of 300 
µm. Of the two, 0.5 ml of surfactant seems to be the optimal amount due to its higher 
apparent porosity and pore size. To ascertain more information on the size of the 
interconnects, mercury intrusion porosimetry (MIP) was performed on two of the samples, 
the scaffolds foamed using 0.2 and 0.5 ml surfactant (Figure 5.12). For comparison, the 0.2 
ml sample was chosen since that was the amount used before in the gel-cast foaming 
process that employed in situ polymerisation. 
 
 
Figure 5.12: Interconnect sizes of scaffolds foamed with 0.2 ml and 0.5 ml of surfactant 
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Figure 5.12 shows the variation in the range of interconnect size between scaffolds foamed 
using different concentrations of surfactant. The scaffold foamed using the higher 
concentration of surfactant (0.5 ml Triton X-100) displayed a modal interconnect size of 110 
µm, with a large majority of the interconnects possessing a diameter greater than 100 µm. 
This indicates it as a suitable candidate for bone ingrowth. As expected, the scaffold foamed 
using the lower concentration of surfactant had a much reduced modal interconnect size of 
60 µm and displayed a tighter range distribution, as suggested by the SEM image in Figure 
(previous one b). The figure highlights the need to re-optimise any processing conditions if 
there is a change in any of its parameters.   
 
Following these preliminary investigations, a base methodology of 25 g of glass in 20 ml of 
DI water and surfactant amount of 0.4 ml, with a sintering temperature of 690 °C for 5 h was 
chosen to enable a systematic study of the process variables to enable optimisation of the 
process and the scaffolds in terms of pore size and mechanical properties. 
 
5.3.1 Shrinkage during sintering 
Using the protocol of 25 g of SBP-3 glass to 20 ml of DI water and foamed with 0.4 ml of 
Triton X-100, followed by sintering at 690°C for 5 h, the samples shrank by roughly 33% in 
each dimension following sintering, leading to 70% shrinkage by volume (Figure 5.13).  
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Figure 5.13: SBP-3 samples a) before sintering b) after sintering 
 
5.3.2 Contaminated particles 
In order to investigate more process variables more glass was needed. More SBP-3 glass frit 
was synthesized and sent off to Hosakawa (Runcorn UK) for jet milling. While the new glass 
powder appeared as normal under observation and handling during scaffold foaming and 
freeze-drying, after the gelatin burn out and sintering, it became apparent the samples were 
contaminated. Figure 5.14b shows the brown colour of the scaffolds after sintering, which is 
symptomatic of iron contamination. Figure 5.14a shows scaffolds that are sintered from 
leftover SBP-3 glass powder that were not contaminated. 
a) b)
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Figure 5.14: a) SBP-3 sintered scaffold b) Contaminated SBP-3 sintered scaffold 
 
Initially, contamination of the sintering furnace was suspected, though that was quickly 
discounted after samples from the previous batch of SBP-3 glass were sintered over several 
separate trials and sintered as normal, without the brown discolouration. Glass frit from the 
new SBP-3 batch that were retained and not sent to be jet milled were also sintered, 
yielding no discolouration, showing no contamination of the frit.  
 
This suggests that the discolouration could have been due to steel contamination during the 
jet milling process, where the abrasive nature of the glass might have picked up steel 
contamination from the steel classifier of the jet milled. The initial batch of SBP-3 glass that 
was jet milled in this manner had an iron concentration of under 85 ppm (from ICP, see 
Table 3.2) and while there were some grey discolouration, it was faint.  
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EDX analysis of the contaminated powder did not detect any iron (Figure 5.15), but only 
small amounts are needed to give discolouration. The presence of tungsten (W) in the figure 
is due to the electron source of the instrument being made of the same material. 
 
 
Figure 5.15: EDX of contaminated SBP-3 glass powder 
 
Assuming iron contamination was present, an attempt was made to remove the iron using a 
magnet. A magnetic sphere was placed into a container with the contaminated powder 
suspended in ethanol. After attempts in agitating the magnet with a stirring rod held outside 
the container proved rather inefficient, the container was then placed onto a stirring plate 
for thirty minutes before it was left to settle once more. Upon removal, the magnetic sphere 
was found to be covered with a scattered layer of particles. Coupled with the fact that the 
contaminated glass emerged from sintering a rust-brown colour, it was deduced that the 
contaminant was from iron from the jet-milling process.  
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Successive applications of the magnetic stirring method continued to produce iron particles 
attached to the magnet, and so trying to remove the contamination seemed fruitless. 
Instead, another batch of glass was synthesized and ground in a Gyro-mill at the Dental 
School, Queen Mary University of London, for 4 minutes. Particle size analysis of the glass 
powder showed that the size distribution of the particles were similar to that obtained by 
jet-milling, with a D50 of 9.6 µm. 
 
5.4 Characterisation of gel-cast foam scaffolds optimised post-
contamination  
Once uncontaminated particulate was obtained, scaffolds were produced using the 
optimised parameters from the previous studies. The process was carried out using 25 g of 
SBP-3 particles (< 32 µm), 20 ml water, 1 g gelatin, 0.4 ml Triton X-100 sintering at 690 °C for 
5h. Figure 5.16 shows SEM images and interconnect size distributions from mercury 
porosimetry for the scaffolds from two batches produced under those conditions on the 
same day. Unfortunately Figure 5.16 shows variability in the process. Batch A had a 
percentage porosity of 80% and a modal interconnect size of 124 µm, giving a maximum 
compressive strength of 6.8 MPa. This would be of great interest to orthopaedic surgeons as 
it gives a good strength with high interconnected porosity. However a subsequent batch 
was more porous (88%) with a more broad distribution of pore sizes (Figure 5.16b). 
The ICP data for the SBP-3 scaffolds was carried out on a batch of scaffolds with 84% 
porosity. Following immersion in SBF were similar to those for the SBP-1 scaffolds (Figure 
5.17). The scaffolds released cations and soluble silica slower than the particulate form for 
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the same glass. This is likely to be due to the particulate having a surface area higher than 
the foam. This was also reflected in the P data. P content in the SBF decreased more rapidly 
for the particulate than it did for the foam, indicating more rapid calcium phosphate 
deposition on the particulate. 
 
 
Figure 5.16: Characterisation of SBP-3 foam scaffolds from two batches using the same process variables. 
They were foamed with 0.4 ml of surfactant and sintered at 690 C for 5 h.  (a) batch A, (b) batch B. 
 
However the Sr release from SBP-3 scaffolds was much lower than it was for the SBP-3 and 
the difference was greater than it was for Ca release. It is not likely that the process of the 
glass would change the role of Sr in the glass network, so it is not clear why this result 
occurred.  
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Figure 5.17: SBF study of SBP-3 powder and scaffolds 
 
Figure 5.18 shows XRD patterns for the SBP-3 particulates, indicating HCA formation at 2 
weeks immersion in SBF. The findings were supported by FTIR spectra, showing P-O bending 
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bands from 2 weeks of immersion onwards (Figure 5.19). The P content in the SBF at 2 
weeks when the particulate was immersed was 15 ppm.  HCA formation was not observed 
on SBP-3 scaffolds. This is likely to be because, according to Figure 5.17, the P content of SBF 
did not reach 15 ppm until 4 weeks of immersion. 
 
 
Figure 5.18: XRD traces of SBP-3 powders after SBF testing. The marked peak at 32° 2θ is indicative of a 
phosphate phase. 
Figure 5.18 shows some XRD traces of the SBP-3 powder of throughout 4 weeks of 
immersion in SBF. While a sharp peak did form at 32 °2θ, it is not indicative of HCA 
formation, which requires peaks at both 26 and 32 °2θ. The 32 °2θ peak does indicate some 
form of phosphate phase depositing however.  
FTIR was also performed on the samples of SBP-3 after SBF testing. The peak that develops 
at 999 cm-1 across the four time points is associated with non-bridging oxygen (NBO) groups. 
Since the peak is there even before immersion, it confirms that glass network is disrupted 
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with modifier ions. There is an upward trend that suggests the glass becoming more 
disrupted over time as more phases are deposited from solution. A peak also develops over 
time at around 570  cm-1. This corresponds to P-O bends. However, HCA typically displays a 
double peak and 575 and 600 cm-1, which these samples do not have. The one P-O bend 
does correlate with the data from XRD in that while HCA doesn’t form for this glass 
composition through SBF testing, other phosphate groups are forming instead. 
 
Figure 5.19: FTIR traces of SBP-3 powders after SBF testing 
 
The slow dissolution rate of the SBP-3 scaffolds is surprising, given their network 
connectivity was calculated to be 2.3 (Table 3.1). The slow dissolution of SBP-1 was 
attributed to Zn acting as a network intermediate. In SBP-3 there is no Zn, but the glass did 
still contain Mg (7.5 mol%). Watts et al. showed that 14% of the Mg can act as a network 
        142 
intermediate in their system. If this happened in SBP-3, NC would increase to 2.4, which 
would still be expected to be bioactive. In order to obtain some experimental data on the 
network connectivity of the glasses, solid state 29Si NMR was run on the glasses. Figure 5.20 
shows that the 29Si spectra for SBP-3 and ICIE-16 were very similar, indicating a similar 
distribution of Q structures. A difference in chemical shift is seen with 13-93, which has a 
much higher silica content and theoretical network connectivity (2.59). There is shift 
towards high Q species. It is therefore not clear why SBP-3 degrades slower and forms HCA 
slower than 13-93 in SBF. Mg is known to inhibit HCA formation, but 13-93 contains 7.7 mol% 
MgO. 
 
Figure 5.20 
29
Si solid state NMR of bioactive glass powders as produced. Courtesy of Dr Robert Law, 
Department of Chemistry. Dotted line is a guide to the eye. 
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5.5 The adapted gel-cast foaming method using other glass 
compositions 
To determine if this new process can be applied to other glass compositions, a brief study 
was conducted with three other compositions. ICIE16 was picked as it was the original glass 
composition used by Wu et al., 1-3-93 was also picked since it is used in many other melt-
derived scaffolds38,68. Due to ongoing interest in the role of strontium in bioactive glasses, 
and whether a 7 component system was vital to the success of the adapted gel-cast foaming 
method thus far, a variant of the SBP-3 composition was produced that did not contain any 
strontium as a basis of comparison (SBP-4). To try to maintain the same network 
connectivity with SBP-4, the 17.80 mol% of SrO present in SBP-3 was replaced with an extra 
17.80 mol% of CaO, giving a total of 35.60 mol% of CaO in SBP-4 whilst maintaining the 
amounts of the other oxides (Table 3.1). Scaffolds were foamed with the same amount of 
components as Section 5.4, only the glasses mentioned in this Section were used in SBP-3’s 
place.  
Literature on 13-93 states that the glass composition can be sintered in 1 h at 700 °C116. 
Since the glass transition temperature of 13-93 is around 600 °C117 and the sample has to be 
held at near its Tg at 500 °C for 1 h prior to sintering, it was decided that its sintering regime 
be brought down to 690 °C for 1 h. The same was decided for scaffolds of ICIE16, since 1 h 
was sufficient to sinter them before. SBP-4 has a similar composition to SBP-3 so it was 
suspected that it would require a similar sintering regime, namely 690 °C for 5 h.  
The samples were placed into the furnace for gelatin burn out and sintering, before being 
examined under the SEM (Figure 5.21).  
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Figure 5.21: Sintered scaffolds of a) 13-93 b) ICIE16 c) SBP-4 produced via the modified gel-cast foaming 
process. Scale bar is 500 µm.  
Figure 5.21a shows the scaffold sintered at 690 °C for 1 h. While it has the characteristics of 
a scaffold with interconnects and pores these structures are extremely small, with modal 
pore size of 100 µm. The surface of the scaffold appears smooth, indicating complete 
sintering, though with such small features it seems to have either over-densified or the 
composition requires more surfactant than 0.4 ml of Triton X-100 to achieve larger pore 
sizes. Figure 21b is an image of a ICIE16 scaffold. The pores on this sample are larger than 
that of 13-93, which pores in the region of 200-500 µm and clearly displayed interconnect 
sizes of around 100 µm. Figure 21c shows a scaffold of SBP-4 sintered at 690 °C for 5 h. 
While it possesses a very open pore structure the surface can be seen to be very granular, 
indicative of incomplete sintering. Indeed, the specimen was very fragile and small granules 
a) b)
c)
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broke from it during handling. This suggests that in order to produce scaffolds with SBP-4, 
the sintering regime has to either be heightened in terms of temperature, or lengthened in 
terms of holding time. Of course, this brings with it the risk of crystallisation, though judging 
from its highly coarse surface it should be able to withstand an increase of 20 °C at the same 
temperature without crystallisation.  
 
5.6 Conclusions 
Overall, it has been shown that the modified gel-cast foaming technique is very versatile, 
allowing for scaffolds of other compositions to be produced with without much need for 
further optimisation. Since it is only a 4 component process, it should not take long to 
narrow down the most optimal production route.  
Another benefit of the new process is that it can be used to produce scaffolds of the ICIE16 
composition and others with higher sodium and potassium content than SBP-3 as it does 
not use the ammonium persulphate initiator.  
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6 Concluding remarks 
The gel-cast foaming method is an effective process for production of melt-derived 
bioactive glass scaffolds with highly interconnected pores and compressive strengths similar 
to cancellous bone. The amorphous structure of the glass can be maintained if certain glass 
compositions are used with specific sintering regimes. The study has demonstrated that a 
variety of glass compositions are compatible with the gel-cast foaming process, requiring 
slight modifications to the methodology for each one. The gel-cast foaming process 
variables, such as the amount of initiator or surfactant, were sensitive to changes in the 
glass composition due to differences in surface charge. 
 
This thesis reports on two main areas. The first was adapting the gel-cast foaming process 
for new glass compositions (SBP-1 and SBP-3) through systematic investigation of the effects 
of the process variables on porosity and mechanical properties. The second was 
development of a new simplified gel-cast foaming process, which removed the in situ 
polymerisation step, replacing it with thermal gelation. The new process was then optimised 
for the SBP-3 composition through systematic investigation of the process variables. 
 
Key variables investigated in the processes were: glass composition; grinding method for the 
frit; amount of glass loading in the slurry; gelatin concentration (new method); surfactant 
concentration; sintering temperature and hold time. Composition and particle morphology 
affected the sintering window. The processing variables affected macroporosity and 
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interconnectivity; strut density; degree of crystallisation; dissolution rate and mechanical 
strength. 
 
Changing the glass composition from ICIE16 to SBP-1 and SBP-3 prevented the formation of 
potassium sodium sulphate crystals on the scaffold surface simply by reducing the sodium 
and potassium content of the glass, reducing the reaction of the dissolution products of the 
glass with the initiator of the in situ polymerisation reaction (ammonium persulphate). The 
glass composition also affected the foaming process however. The surfactant concentration 
had to be increased to maintain pore size. Changing the glass inevitably changed the glass 
transition temperature and crystallisation temperature, requiring a new sintering regime. 
Increasing sintering temperature increased the degree of sintering of the glass particles and 
therefore increased the density of the strut walls (increasing mechanical strength) but if the 
temperature increased above 700 °C some crystallisation of the glass occurred. The 
crystallisation onset was lower than shown by thermal analysis of the as-produced powder. 
This was due to the interaction of the water of the process with the glass particles. Water 
was needed in the process to allow the surfactant to function.   
 
The optimal processing method for the SBP-3 composition using the in situ polymerisation 
method was: 20 g of glass (D50 9 µm) in 18 ml of water; 6 g methacryl amide (monomer); 3 g 
N,N’-methylenebisacrylamide (cross-linker); 2 drops of Dispex (dispersant); 2 ml ammonium 
persulphate (initiator); 3 ml TEMED (catalyst); foamed with 0.2 ml Triton X-100 (surfactant) 
for 90s; heat to 350 °C for 1h; sinter at 690 °C for 1h. 
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The optimal processing method for the SBP-3 composition using the thermal gelation 
method was: 25 g of glass (D50 9 µm) in 20 ml of water; 1 g of gelatin (porcine skin); 0.4 ml 
Triton X-100 (surfactant); foaming for 2 minutes at 35 °C; cooling in an ice bath for 6 
minutes;  freeze-drying. 
 
Other important projects included up-scaling of the gel-cast foaming process and in vitro 
and in vivo testing. Up-scaling of the original process was only partially successful with 
batches 5x lab-scale being produced but with a reduced modal interconnect size (65 µm). 
 
Through collaboration, it was found that the SBP-3 foams made through the original process 
caused some cell toxicity in vitro (cell viability slightly lower than the control), which was 
overcome when scaffolds were produced by the thermal gelation gel-cast foaming process. 
The toxicity was attributed to the potassium sulphate crystals that formed during the in situ 
polymerisation. 
 
However, in vivo tests on the up-scaled scaffolds showed impressive results. The 
collaboration on in vivo studies showed remarkable bone ingrowth into the SBP-3 scaffolds 
produced by the original gel-cast foaming method, with 99% of the glass scaffold surface 
being covered with new bone at 91 days. This is despite the scaffolds showing low 
bioactivity and slow dissolution in SBF compared to ICIE16. This could mean the network 
connectivity of the SBP-3 glass was higher than expected, which was supported by density 
calculations and measurements (3.07 gcm-3 is high compared to ICIE16). While the 
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theoretical network connectivity of the SBP-3 was 2.3 (compared to 2.13 for ICIE16), the 
dissolution data in SBF was typical of a glass with even higher connectivity. Higher network 
connectivity could be due to the cations (e.g. Mg2+, Sr2+) behaving as network intermediates 
rather than network modifiers. However the 29Si NMR suggested that the Q structures of 
ICIE16 and SBP-3 were similar. Qualitatively the SBP-3 scaffolds appeared to degrade faster 
in vivo than in SBF, with the interconnects between the pores increasing (e.g. from ~65 µm 
to ~100 µm in 91 days) although this is difficult to prove. 
 
The thesis therefore shows that porous amorphous glasses can be produced, by an 
optimised gel-cast foaming process, which are suitable for bone regeneration. However it 
raises questions on the mechanism of bioactivity. 
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7 Future Work 
The promising in vivo data for the SBP-3 scaffolds is of interest, warranting further 
investigation of porous bioactive glasses. The first thing to investigate further is the 
mechanism of bioactivity of the SBP-3 foams. There was no evidence of the typical HCA 
layer and silica-rich layer on the foams in the ex-vivo images. This should be verified. The 
lack of a thick HCA layer would correlate with the SBF studies that show low rates of HCA 
formation. The question then is why is the bone ingrowth and bone-material contact so high? 
The bioactivity mechanism could be a combination of that normally seen in bioactive glasses 
(ion exchange, HCA deposition) and that seen in synthetic hydroxyapatite (cell-mediated). 
The slow dissolution (compared to Bioglass) of the glass may be beneficial. Recent studies 
on sol-gel foam scaffolds with similar pore size, but higher rates of dissolution, showed no 
bone growth in vivo, which was attributed to high pH inside the pores118. This was solved by 
pre-soaking the foams. The SBP-3 foams did not need the pre-soak and did not cause 
toxicity in vitro. The question then is whether the SBP-3 foams can be remodelled over the 
time scale of the natural regeneration of a bone defect (e.g. 1 year).  Further studies in the 
short term therefore should be: 
1. In vivo testing (sheep model) of SBP-3 foams made with the new thermal process 
with the same interconnet sizes (65 µm) and scaffolds with a larger interconnect size 
(e.g. 200 µm) over longer time frames to look at remodelling mechasims (of bone 
and scaffold).  
2. Comparison to ICIE16 or 13-93 scaffolds with the same porosity. The reason would 
be that these scaffolds show more rapid HCA formation in vitro. 
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If the SBP-3 glass scaffolds degrade too slowly in vivo for successful remodelling, the pH 
burst of the more highly degradable scaffolds could be reduced by improving fluid flow into 
(and out of) the scaffolds in vivo. This would also potentially increase the rate of blood 
vessel ingrowth. A potential way of improving fluid flow is to reduce the tortuosity of the 
pore network. Recent studies on robocasting (a type of 3-D printing) have shown that high 
strength glass scaffolds can be produced with 3-D grid-like structures. The line of sight pore 
channels can provide high rates of fluid exchange. It would be highly beneficial to compare a 
bioactive glass foam and a 3-D printed scaffold with the same composition and interconnect 
sizes in an in vivo model. 
A possible method to further reduce the risk of contamination during frit grinding is to use 
ball milling with agate media. Agate is composed of microcrystalline silica and thus any 
contamination during grinding will only increase the silica content of the batch by a small 
margin. The particle morphology of the resulting powder however would not be the same as 
that produced via jet milling or gyro-milling, with the particles tending towards rounder 
morphologies that may affect sintering to an extent.  
One of the reasons SBP-3 has a large sintering window is the presence of several different 
cations in its composition. While strontium has potential therapeutic benefits in orthopaedic, 
FDA approval of a glass releasing Sr ions is yet to be attained. It would therefore be 
worthwhile investigating whether the in vivo results were so promising because of the 
presence of strontium or whether a strontium-free glass (e.g. SBP-4) with similar 
morphology would produce the same result. The role of strontium in the structure of SBP-3 
and its effect on the sintering window would also be of interest. 
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